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“We must not forget that when radium was discovered no one knew that it 
would prove useful in hospitals. The work was one of pure science. And this 
is a proof that scientific work must not be considered from the point of 
view of the direct usefulness of it. It must be done for itself, for the beauty 
of science, and then there is always the chance that a scientific discovery 
may become like the radium a benefit for humanity. ”  
- Marie Curie, Lecture at Vassar College, 1921- 
 
The scientist is not a person who gives the right answers, he's one who asks 
the right questions.   
-Claude Lévi-Strauss, Le Cru et le cuit, 1964- 
 
 
 
 
 
 
 
dedicated to my parents 
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Mitochondrial Ca2+ uptake and release play a pivotal role in different physiological 
processes such as intracellular Ca2+ signaling and cell metabolism, while their 
dysregulation can lead to cell death induction. In energized mitochondria the Ca2+ 
uniporter (MCU) mediates Ca2+ uptake across the inner mitochondrial membrane (IMM) 
while the Na+/Ca2+ exchanger and the H+/Ca2+ exchanger are responsible for Ca2+ efflux. 
However, when mitochondrial matrix Ca2+ load exceeds the capacity of the efflux 
pathway by exchangers, an additional pathway for Ca2+ release from mitochondria may 
exist through opening of the permeability transition pore (PTP). The mitochondrial 
permeability transition (PT) describes a process of Ca2+-dependent, tightly regulated 
increase in the permeability of the IMM to solutes with molecular masses below 1500 
Da, due to the opening of a high-conductance channel, the PTP. Prolonged PTP 
opening causes several effects, such as depolarization, osmotic swelling, outer 
mitochondrial membrane rupture and release of apoptogenic proteins like cytochrome 
c (cyt c). Transient openings of the PTP on the other hand, might be involved in 
physiological Ca2+ homeostasis and may protect mitochondria from Ca2+ overload. 
Several studies allowed a thorough characterization of the functional properties and 
regulation of the putative channel, but its molecular nature remains still elusive. One of 
the best defined modulators of the PTP is the mitochondrial peptidyl-prolyl-cis-trans-
isomerase (PPIase) Cyclophilin D (Cyp-D), that plays an important role in protein folding 
and can be selectively inhibited by the immunosuppressant drug  Cyclosporin A (CsA).  
In spite of its importance as a model organism and as a genetic tool, remarkably little is 
known about the properties of Ca2+ transport in mitochondria of the fruit fly Drosophila 
melanogaster, and on whether these mitochondria can undergo a PT. In this study we 
have characterized the pathways of Ca2+ transport in the digitonin-permeabilized 
embryonic Drosophila cell line S2R
+. We demonstrated the presence of ruthenium red-
sensitive Ca2+ uptake, and of Na+-stimulated Ca2+ release in energized mitochondria, 
which match well characterized Ca2+ transport pathways  of mammalian mitochondria. 
Furthermore we identified and characterized a novel mitochondrial Ca2+-dependent 
Ca2+ release channel in Drosophila. Like the mammalian PTP, Drosophila Ca2+ release is 
inhibited by tetracaine and opens in response to matrix Ca2+ loading, IMM 
depolarization and thiol oxidation. As the yeast pore (and at variance from the 
SUMMARY 
 
4 
mammalian PTP), the Drosophila channel is inhibited by Pi and insensitive to CsA. A 
striking difference between the pore of Drosophila and that of mammals is its selectivity 
to Ca2+ and H+ and the lack of mitochondrial swelling and cyt c release during the 
opening of the channel.  
The apparent absence of a mitochondrial Cyp in Drosophila prevents an investigation 
based on the effects of CsA, a classical inhibitor of the mammalian PTP. Thus, in the 
second part of this study we expressed human Cyp-D in Drosophila S2R
+ cells in order to 
investigate its impact on the Ca2+-induced Ca2+ release channel. Preliminary Ca2+ 
retention capacity studies demonstrated that human Cyp-D induces opening of the 
Drosophila Ca2+ release channel in a rotenone-sensitive but CsA-insensitive manner. If 
the Cyp-D in Drosophila cells changes selectivity, size and properties of the Ca2+-
induced Ca2+ release channel can now be addressed. 
We conclude that Drosophila mitochondria possess a selective Ca2+ release channel with 
features intermediate between yeast and mammals that is probably involved in Ca2+ 
homeostasis but not in Ca2+-mediated cell death induction. In this study we paved the 
way for the application from the sophisticated genetic strategies that Drosophila 
provides to define the molecular nature of the PTP and its role in pathophysiology of 
Ca2+ homeostasis. 
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7 SOMMARIO 
L’accumulo e il rilascio di Ca2+ da parte dei mitocondri svolge un ruolo centrale in diversi 
processi fisiologici, come nelle vie di segnalazione intracellulari e nel metabolismo 
cellulare, mentre la loro disregolazione può indurre la morte cellulare. In mitocondri 
energizzati, l’uniporto del Ca2+ (MCU) media l’accumulo di Ca2+ attraverso la membrane 
mitocondriale interna (MMI) mentre gli scambiatori Na+/Ca2+ e H+/Ca2+ sono responsabili 
del suo efflusso. Tuttavia, quando il carico di Ca2+ nella matrice mitocondriale supera la 
capacità di efflusso attraverso gli scambiatori, potrebbe attivarsi una via aggiuntiva di 
rilascio di Ca2+, attraverso l’apertura del poro di transizione di permeabilità (PTP). La 
transizione di permeabilità (TP) consiste nell’aumento della permeabilità della MMI a 
soluti con massa molecolare inferiore a 1500 Da, è un processo Ca2+-dipendente, 
strettamente regolato, e dovuto all’apertura di un canale ad alta conduttanza, il PTP. La 
prolungata apertura del PTP provoca diversi effetti, come la depolarizzazione, il 
rigonfiamento osmotico, la rottura della membrana mitocondriale esterna e il rilascio di 
proteine pro-apoptotiche come il citocromo c (cit c). L’apertura transiente del PTP, 
invece potrebbe essere coinvolta nell’omeostasi fisiologica del Ca2+ e potrebbe 
proteggere i mitocondri da un sovraccarico dello stesso. Diversi studi hanno consentito 
una caratterizzazione accurata delle proprietà funzionali e della regolazione del canale 
putativo, ma la sua natura molecolare rimane ignota. Uno dei miglior modulatori 
caratterizzati del PTP è la peptidil-prolil-cis-trans-isomerasi mitocondriale Ciclofilina D 
(Cip-D), che svolge un ruolo importante nel ripiegamento delle proteine e può essere 
selettivamente inibita dal farmaco immunosoppressore Ciclosporina A (CsA). 
Nonostante la sua importanza come organismo modello e come strumento genetico, 
poco si conosce a proposito delle proprietà di trasporto di Ca2+ mitocondriale del 
moscerino della frutta Drosophila melanogaster e dell’eventualità che i suoi mitocondri 
possano subire una TP. In questo studio abbiamo caratterizzato le vie di trasporto di 
Ca2+ mitocondriale nella linea cellulare embrionica di Drosophila S2R
+, permeabilizzata 
con la digitonina. Abbiamo dimostrato la presenza di un effettivo accumolo di Ca2+, 
sensibile al rosso rutenio, come anche il rilascio di Ca2+ stimolato dal Na+ in mitocondri 
energizzati, processi che corrispondono alle ben caratterizzate vie di trasporto di Ca2+ in 
mammiferi. Inoltre, abbiamo identificato e caratterizzato un nuovo canale di rilascio del 
Ca2+ indotto dal Ca2+ stesso in Drosophila. Come il PTP dei mammiferi, il canale di 
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rilascio di Ca2+ in Drosophila è inibito da tetracaina e apre in risposta al carico di Ca2+ 
nella matrice, depolarizzazione della MMI ed ossidazione di tioli. Come il poro in lievito 
(e in contrasto con il PTP dei mammiferi), il poro di Drosophila è inibito da Pi e 
insensibile alla CsA. Le principali differenze  il poro di Drosophila e quello dei mammiferi 
sono la sua selettività per Ca2+ e H+, e la mancanza di rigonfiamento mitocondriale e il 
rilascio di cit c conseguente all’apertura del canale. 
L’apparente assenza di una Cip mitocondriale in Drosophila impedisce uno studio basato 
sugli effetti della CsA, un classico inibitore del PTP dei mammiferi. Perciò, nella seconda 
parte di questo studio abbiamo espresso la Cip-D umana nelle cellule S2R
+ di Drosophila 
al fine di indagare il suo impatto sul canale di rilascio del Ca2+. Preliminari studi di 
capacità di ritenzione del Ca2+ hanno dimostrato che la Cip-D umana induce l’apertura 
del canale di rilascio del Ca2+ in Drosophila in modo rotenone-sensibile ma CsA-
insensibile. Se la Cip-D in Drosophila cambia la selettività, la grandezza e le proprietà del 
canale di rilascio del Ca2+ può ora essere investigato. 
Concludiamo che i mitocondri di Drosophila possiedono un canale selettivo di rilascio di 
Ca2+ con caratteristiche intermedie tra il lievito e i mammiferi che probabilmente è 
coinvolto nell’omeostasi del Ca2+, ma non nell’induzione della morte cellulare mediata 
dal Ca2+. In questo studio abbiamo spianato la strada per l’applicazione delle strategie di 
genetica sofisticate, che la Drosophila offre per definire la natura molecolare del PTP ed 
il suo ruolo nella patofisiologia dell’omeostasi del Ca2+. 
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15 INTRODUCTION 
1 Mitochondria 
Mitochondria are organelles found in the cytoplasm of every eukaryotic cell with the 
exception of red blood cells and of amitochondrial eukaryotic organisms such as Giardia 
intestinalis and Trachipleistophora homi1,2. Their most prominent roles are the supply of 
energy in form of the high-energy molecule ATP and the regulation of cellular 
metabolism. In addition, mitochondria are involved in a wide range of other processes, 
such as Ca2+ homeostasis, cellular differentiation, control of cell cycle, cell growth and 
cell death3. 
 
1.1 Mitochondrial morphology  
During live cell imaging it becomes immediately apparent that mitochondrial 
morphology is far from static and that mitochondria are mobile and plastic organelles, 
constantly changing their shape. They can undergo fission and fusion, events which in 
mammals are regulated by the proteins OPA1, MFN1, MFN2 and DRP1(4), or move along 
the cytoskeleton via specific motor proteins5, a process of critical importance in axons. 
Thus, mitochondrial morphology varies widely among different cell types depending on 
the balance between the rates of fission and fusion. In some cells they form long 
filaments or chains as in fibroblasts. In others they remain fixed in one position where 
they provide ATP directly to a site of high ATP consumption, e.g. in myofibrils.  
 
 
Figure 1. Mitochondrial morphology in fibroblasts and cardiomyocytes. (A) Fluorescence imaging of reticular 
mitochondrial network in human fibroblasts (green) composed of filamentous tubules that frequently change shape 
due to high rates of fission and fusion; from
6
. (B) Mitochondrial morphology in cardiomyocytes. Fluorescence live-cell 
imaging of adult rat cardiomyocyte mitochondria (red). The mitochondria account for about 35% of total cell volume 
and are arranged longitudinally along the myofibrils at the sarcomeric A-band, providing the majority of ATP needed 
for contraction and ion homeostasis; from
7
. 
A B
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Mitochondria possess their own genome consisting of a single circular DNA molecule8 
encoding for 2 ribosomal RNAs (rRNAs), 22 transfer RNAs (tRNAs), and 13 polypeptides 
(all of them components of the respiratory chain/oxidative phosphorylation system). 
The majority of mitochondrial proteins, however, are encoded by the nuclear genome, 
requiring import into the mitochondria following translation.  
 
 
Figure 2. Cryotomogram from isolated rat liver mitochondrion. OMM: outer mitochondrial membrane, IMM: inner 
mitochondrial membrane; modified from
9
. 
 
Each mitochondrion has two highly specialized membranes, the inner and the outer 
membrane, which have very distinct functions. Together they create two separate 
mitochondrial compartments: the internal matrix and a narrow intermembrane space 
(IMS). The inner mitochondrial membrane (IMM) is folded into numerous cristae, which 
expand its surface area. The outer mitochondrial membrane (OMM) contains many 
copies of the voltage-dependent anion channel (VDAC), which forms large aqueous 
channels through the lipid bilayer and allows ions, metabolites and small molecules to 
move between the cytoplasm and the mitochondria. Such molecules can enter the IMS, 
but most of them cannot pass the impermeable IMM, which contains a high proportion 
of the phospholipid cardiolipin, making it especially impermeable to ions. IMM 
permeability is mediated by a variety of specialized membrane channels, transporters 
and exchangers that make the latter selectively permeable to ions and small molecules 
which are metabolized or required by the mitochondrial enzymes located in the matrix. 
The IMM is a very good electric insulator and can keep a potential difference of -180 
mV10. Proton pumping driven by electron flow through the respiratory chain constantly 
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generates an electrochemical gradient (ΔμH), which is composed of a membrane 
potential difference (ΔΨ) and a proton concentration difference (ΔpH). The proton 
gradient provides the driving force for ATP synthesis and for ion and metabolite 
transport. The IMM contains also the energy transducing macromolecular complexes of 
the respiratory chain. 
 
1.2 Mitochondrial energy production 
Living organisms require a constant input of energy to carry out movement like muscle 
contraction, active transport of molecules and ions as well as the synthesis of 
biomolecules from simple precursors. In most processes the carrier of free energy is 
adenosine triphosphate (ATP). Ingested glucose is converted to pyruvate in a process 
known as glycolysis, taking place in the cytoplasm of any cell. In this process only a very 
small fraction of the total free energy potentially available from glucose is used to 
synthesize ATP. The metabolism of the sugar is completed in the mitochondria, where 
pyruvate is imported and eventually oxidized to CO2 and H2O through the combined 
operation of the Krebs cycle, the respiratory chain and the FOF1 ATP synthase, whereby 
15 times more energy is converted to ATP than in glycolysis. Initially, pyruvate is 
metabolized to the intermediate acetylCoA and afterwards oxidized in the citric acid 
cycle by a series of enzymatic reactions taking place in the mitochondrial matrix. End 
products of this oxidation are CO2, which is released from the cell as waste, and the 
activated electron carrier molecules NADH and FADH2, the sources of electrons for 
transport along the respiratory chain. The enzymes of the electron transport chain are 
located in the IMM and most of them are arranged into three large enzymatic 
complexes, which as described later function also as H+-pumps. Each complex is 
composed of electron carriers, associated with and held in close proximity by different 
protein molecules. The three intermembrane complexes are linked by two mobile 
electron carriers. The main purpose of making electrons pass through a chain of 
electron carriers with increasing reduction potential (increasing affinity for electrons), is 
to divide the energetically favorable reaction H2 + ½ O2  H2O into small steps, so that 
most of the energy released can be stored instead of being lost to the environment as 
heat. Thus, the electrons start with high energy and gradually lose it as they pass along 
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the chain. The flow of electrons from the energy-rich molecules NADH and FADH2 to 
the final acceptor O2 can be subdivided into the following steps. 
 
Complex I: (NADH Dehydrogenase complex) accepts electrons from NADH and passes 
them through a flavin and several iron-sulfur centers to ubiquinone (Q). The electrons 
emerge in QH2, the reduced form of Q. This highly mobile hydrophobic molecule then 
transfers its electrons to a second respiratory enzyme complex, the Cytochrome b-c1 
complex. Complex I can be specifically inhibited by rotenone. Q also receives electrons 
from FADH2 produced by the oxidation of succinate in the citric acid cycle by an enzyme 
complex called Succinate Dehydrogenase (Complex II). Complex II is the only 
respiratory complex which does not pump protons.  
 
Complex III: (Cytochrome b-c1 complex) functions as a dimer. Each monomer contains 
three hemes bound to cytochromes and an iron-sulfur protein. The complex accepts 
electrons from Q and passes them on to cytochrome c (cyt c), a water-soluble 
peripheral membrane protein, which is like Q a mobile electron carrier. It passes its 
electrons to the Cytochrome Oxidase complex. Complex III can be specifically inhibited 
by antimycin A which blocks the respiratory chain between cytochrome b and 
cytochrome c1.  
 
Complex IV: (Cytochrome Oxidase complex) is also composed of a dimer; each 
monomer contains two cytochromes and two copper atoms. The complex accepts one 
electron at a time from cyt c and passes them four at a time to oxygen, the ultimate 
electron acceptor to form H2O. Complex IV can be specifically inhibited by cyanide, 
which prevents respiration with all substrates. 
 
The flow of electrons across the respiratory chain and the thereby released energy is 
coupled to proton pumping across the IMM, from the matrix to the IMS. This generates 
a proton gradient, which is largely contributed by the inside negative ΔΨ. The resulting 
proton motive-force is the link between the electron flow in the respiratory chain and 
the synthesis of ATP. The FOF1 ATP synthase (complex V) localized in the IMM uses the 
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ΔμH to drive the energetically unfavorable reaction between ADP and Pi to synthesize 
ATP.  
 
Structure of the ATP synthase (complex V) 
The mitochondrial FOF1 ATP synthase is a multi-subunit protein localized in the IMM 
and composed of a catalytic F1 and a membrane-bound FO part. The F1 region comprises 
the subunits α, β (3 of each), γ, δ and ε whereas the FO region comprises subunits a, b, c 
(multiple subunits, 8 in mammals), d, e, f, g, A6L and F6
11, 12. The F1 and FO parts are 
connected by a central stalk formed by the subunits γ, δ, and ε as well as by a peripheral 
stalk, comprised of the oligomycin sensitivity conferring protein (OSCP) and subunits b, 
d, and F613. ATP synthesis is based on a rotary catalytic mechanism. H+ translocation 
through the FO region induces rotation of the membrane-bound c-ring, which is 
organized like a barrel within the membrane. Spinning of the c-ring induces the rotation 
of the central stalk (which is attached to the c-ring) inside the α3β3 hexamer of the F1 
part14. This process drives ATP synthesis by inducing conformational changes in three 
catalytic nucleotide binding sites located at interfaces between α- and β-subunits11. 
During rotation, the F1 region is held stationary relative to the FO region by the 
peripheral stalk, a connection which is essential for the proper function of the enzyme15.   
In absence of a proton gradient the ATP synthase can function in reverse, pumping 
protons into the IMS and hydrolyzing ATP in order to create a mitochondrial membrane 
potential (ΔΨm). Furthermore ATP synthase can associate with the inhibitor protein 1 
(IF1) which inhibits hydrolysis of the enzyme. IF1 acts as a dimer and binds to the α-β 
interfaces of two F1-ATPases via its N-terminal inhibitory sequence
16. Binding of IF1 
requires ATP and is favored by low pH and ΔΨm. The restoration of ΔΨm favoring ATP 
synthesis displaces IF1 from the FOF1 ATP synthase
17. 
In eukaryotic mitochondria oligomycin can inhibit FOF1 ATP synthase, by binding to 
subunit c18. It thereby blocks synthesis as well as hydrolysis of ATP and abolishes ADP-
stimulated respiration in intact mitochondria.  
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Figure 3. Schematic representation of the mitochondrial respiratory chain, composed of four multimeric complexes, 
and of the ATP synthase (complex V). Shown are the set of reactions that transfer electrons from reduced cofactors 
to oxygen, obtaining water (yellow curved arrows).  Electron transport between complexes I to IV is coupled to 
extrusion of protons from complexes I, III and IV into the intermembrane space (yellow straight arrows), creating an 
electrochemical gradient (ΔμH) across the inner mitochondrial membrane (IMM). Protons then enter in the c-subunit 
(red straight arrow) of complex V, the ATP synthase, causing the ring of c-subunits to spin (black curved arrow) and 
driving the synthesis of ATP from ADP and Pi (red curved arrow). Some common specific inhibitors for complex I, III 
and IV as well as for the ATP synthase are shown (black arrows on top); modified from
19
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1.3 Mitochondrial control of apoptosis 
Mammalian cell death is most widely classified into two processes, apoptosis or 
necrosis. Cells undergoing a sudden stress situation such as infection or exposure to 
toxins die by necrosis resulting in loss of plasma membrane integrity, uncontrolled 
release of cellular components and inflammation. On the contrary, apoptosis is a 
genetically encoded and highly regulated form of cell death that governs normal body 
sculpture, defense against pathogen invasion and developmental processes.  Exposure 
of the cell to an apoptotic stimulus leads to a series of morphological changes such as 
rounding up of the cell, pseudopod retraction, cell shrinkage, chromatin condensation 
and nuclear fragmentation20. Thus, apoptosis enables the body to eliminate a damaged 
cell without affecting the neighboring environment. Its abnormal regulation is 
associated with many human pathologies such as degenerative diseases (too much 
apoptosis) or cancer (too little apoptosis). Until recently necrosis and apoptosis were 
considered to be two distinct phenomena. However, there is now evidence that both 
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processes can be interconnected and that necrosis can be initiated by death receptors 
usually involved in apoptototic cell death in a process called necroptosis21.  
The key player in the execution of apoptosis is a family of cysteinyl aspartate-directed 
proteases called caspases. These enzymes are synthesized as inactive zymogens (called 
pro-caspases) in healthy cells and can be activated by proteolytic cleavage upon 
triggering by a diverse range of internal and external stimuli22. Upon receipt of 
apoptotic stimuli, cells activate initiator caspases (such as caspase-2, -8, -9, and -10) 
that, in turn, proteolytically activate effector caspases (such as caspase-3, -6, and -7). 
Once active, effector caspases cleave different substrates, eventually leading to the 
dismantling of the dying cell23. Activation of the initiator caspases may occur through 
either an extrinsic or an intrinsic pathway. 
Extrinsic pathway 
The extrinsic pathway of apoptosis is mediated by activation of the so called death 
receptors TNF, FAS or TRAIL. Upon binding of death ligands (such as members of the 
tumor necrosis factor receptor superfamily) on the plasma membrane, conformational 
changes in the receptors lead to the recruitment of adapter proteins on the cytoplasmic 
side and thus the formation of the death-inducing signaling complex (DISC) and 
subsequent activation of pro-caspase-8. Active caspase-8 in turn proteolytically 
processes effector caspases (-3, -6 and -7) leading to further caspase activation events 
which result in substrate proteolysis and cell death. Caspase-8 can also engage the 
intrinsic apoptotic pathway through cleavage of the Bcl-2 homology 3 (BH3)-only 
protein Bid24. Truncated Bid (tBid) translocates to the mitochondria, where it triggers 
activation of the intrinsic apoptotic pathway by promoting mitochondrial outer 
membrane permeabilization (MOMP) and release of apoptogenic proteins25. 
Intrinsic pathway 
The intrinsic pathway of apoptosis can be induced by many different stimuli such as 
oxygen radicals, γ-irradiation, hypoxia or ischemia-reperfusion and converges on the 
central death machinery at the mitochondria. The key event in the intrinsic pathway is 
MOMP and release of mitochondrial apoptogenic proteins, usually located in the IMS, 
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into the cytosol. Once in the cytosol, apoptotic proteins such as cyt c, apoptosis 
inducing factor (AIF), second mitochondria-derived activator of caspases (Smac)/direct 
inhibitor of apoptosis binding protein with low pI (Diablo), and endonuclease G (endoG), 
are able to initiate caspase-dependent or caspase-independent mechanisms that 
promote apoptosis. In caspase-dependent signaling, the most critical apoptogen cyt c 
binds to the adapter protein apoptotic protease-activating factor-1 (Apaf-1), changing 
its conformational state and leading to its oligomerization as well as to the recruitment 
of the effector caspase-9. The complex built of cyt c, Apaf-1 and caspase-9 is called 
apoptosome and its formation is highly ATP-dependent26. The apoptosome in turn 
leads to the downstream activation of other effector caspases and proteolytic cleavage 
of target proteins. The function of active caspases can be blocked by the inhibitors of 
apoptotic proteins (IAPs), whereas Smac/Diablo once released from the IMS binds to 
and inhibits the effects of IAPs, thereby indirectly enhancing the activation of caspases. 
In addition, AIF and endoG translocate to the nucleus where they induce nuclear 
chromatin condensation and DNA fragmentation in a caspase-independent manner27.  
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Figure 4. Intrinsic and extrinsic pathway of apoptosis. In the intrinsic apoptotic pathway, pro-apoptotic BH3 proteins 
of the Bcl-2 family are activated by diverse noxious stimuli, and inhibit anti-apoptotic proteins (Bcl-2 or Bcl-xL). Thus, 
Bax and Bak are free to induce mitochondrial permeabilization with release of cytochrome c, which ultimately results 
in formation of the apoptosome and subsequent activation of the caspase cascade. The outer membrane 
permeabilization can be induced by the permeability transition pore (PTP) as well. SMAC/DIABLO is also released after 
mitochondrial permeabilization and acts to block the action of inhibitors of apoptosis proteins (IAPs), which inhibit 
caspase activation. In the extrinsic apoptotic pathway, ligation of death receptors recruits the adaptor protein FAS-
associated death domain (FADD) to form the death-inducing signaling complex (DISC). This in turn recruits caspase-8, 
which ultimately activates caspase-3, the key effector caspase. There is a cross-talk between the two pathways, which 
is mediated by the truncated form of Bid (tBid) that is produced by caspase-8-mediated Bid cleavage; tBid acts to 
inhibit the Bcl-2-Bcl-xL pathway and to activate Bax and Bak. Apaf1: apoptotic protease-activating factor 1, TNF: tumor 
necrosis factor, TRAIL: TNF-related apoptosis-inducing ligand; modified from
28. 
 
The mechanisms by which MOMP occurs and mitochondrial apoptogenic factors are 
released into the cytosol are still unresolved and different models which are not 
mutually exclusive have been proposed. One of these models involves members of the 
Bcl-2-family, which can be grouped into pro-apoptotic or anti-apoptotic proteins. All of 
them contain one or more Bcl-2 homology (BH) domains, which are important for 
heterodimeric interactions among the different members of the family29. Anti-
apoptotic Bcl-2 proteins (such as Bcl-2, Bcl-xL or Bcl-w) and pro-apoptotic Bcl-2 proteins 
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(such as Bax, Bak, or Bok/Mtd) display four BH domains. The proapoptotic BH3-only 
proteins (such as Bid, Bad, Noxa or Puma/Bbc3), on the other hand, possess only a short 
motif called the BH3 domain as their name indicates. Through their BH3 domain, these 
proteins either inhibit anti-apoptotic proteins or stimulate oligomerization of the 
multidomain proteins Bax and Bak leading to MOMP. Bax proteins can be found as 
monomers in the cytosol. Upon activation the latter translocate to and insert into the 
OMM30, while Bak is present in the OMM even if not activated31. Following activation, 
Bax and Bak undergo conformational changes, oligomerize and form pores in the 
OMM, inducing thus the release of the previously described apoptogenic proteins32. 
This mechanism remains only poorly characterized and it seems unlikely that Bax-/Bak 
channels are large enough to release the bigger pro-apoptotic proteins such as the 
serine protease Omi-Htr2. Another mechanism leading to MOMP through opening of 
the mitochondrial permeability transition pore (PTP) will be discussed in more detail 
below. 
 
2 Cellular Ca2+ homeostasis  
Ca2+ ions are among the most important second messengers and play a key role in cell 
signaling. Most cell types are able to translate the information obtained by a variety of 
stimuli through an increase in intracellular [Ca2+] with highly defined spatial and 
temporal patterns.  This can be achieved by the storage of Ca2+ in specialized 
compartments such as the endoplasmic reticulum (ER), by the low permeability of the 
plasma membrane to ions and by the activity of the plasma membrane Ca2+-ATPase 
(PMCA, pumping Ca2+ outside the cell) and of the Na+/Ca2+ exchanger (NCLX)33. Due to 
these mechanisms the cell is able to keep very low cytoplasmic free [Ca2+] levels in 
resting conditions (~100 nM). Upon stimulation, local changes in cytoplasmic [Ca2+] due 
to fast release from the Ca2+ stores via highly selective channels can be sensed by Ca2+ 
dependent enzymes (such as kinases or phosphatases) or target proteins with direct 
Ca2+-binding sites, that in turn induce specific cellular responses (e.g. contraction, 
secretion, proliferation or cell death).  
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Figure 5. Schematic representation of the Ca
2+
 homeostatic network between endoplasmatic reticulum, 
mitochondria and cytosol.  cADPr, cyclic ADP ribose receptor; CICR, calcium-induced calcium release channel; DAG, 
diacylglycerol; DHPR, dihydropyridine receptor; GPCR, G protein-coupled receptor; IP3, inositol triphosphate; PLC-β, 
phospholipase C-β; PM Ca
2+
 channel, plasma membrane calcium channel; PMCA, plasma membrane channel pump; 
RyR, ryanodine receptor; SERCA, sarco/endoplasmic reticulum Ca
2+
 ATPase; modified from
33
. 
 
2.1 The role of mitochondria  
The first hint on the important role of mitochondria in Ca2+ handling was the 
demonstration of Ca2+ accumulation in isolated energized rat kidney mitochondria half 
a century ago34. Today it is known that mitochondria play a pivotal role in cellular Ca2+ 
homeostasis and that they are thereby involved in a wide field of physiological 
processes such as buffering of cytoplasmic Ca2+ signals, excitation-contraction coupling 
and induction of cell death. In healthy cells the mitochondrial matrix [Ca2+] is low. When 
Ca2+ is released from the Ca2+ stores into the cytoplasm, microdomains of high [Ca2+] 
(10-20µM) can transiently form in regions of close proximity between mitochondria and 
Ca2+ channels of the ER or the plasma membrane35. Mitochondria in these regions 
rapidly accumulate Ca2+ and then gradually release it when plasma membrane ion 
pumps have lowered the cytoplasmic free [Ca2+], thus amplifying and sustaining signals 
arising from cytoplasmic [Ca2+] increases.  Furthermore, mitochondrial Ca2+ uptake can 
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profoundly influence cell survival, as excess matrix [Ca2+] can initiate cell death through 
opening of the PTP (as discussed below). Thus, the mechanisms controlling cellular and 
mitochondrial Ca2+ homeostasis, metabolism and bioenergetics have to be tightly 
integrated in the overall cellular Ca2+ homeostatic network36. 
 
2.2 Mitochondrial Ca2+ influx and efflux mechanisms  
Ca2+ uptake into respiring mitochondria is an energy dependent, electrophoretic 
process driven by the Ca2+ electrochemical gradient ΔμCa, favored by the inside-
negative ΔΨm and mediated by the mitochondrial Ca
2+ uniporter (MCU). In the last four 
decades the MCU has been characterized in terms of thermodynamic properties and 
inhibitor specificity (with ruthenium red and lanthanides being the most potent 
inhibitors) and was recently shown to be a highly selective, low conductance channel by 
electrophysiology37. In 2011 two groups independently identified a 40kD protein with 
two transmembrane domains to be the MCU38, 39. The influx of Ca2+ via the MCU is 
charge-compensated by increased H+ pumping of the respiratory chain, resulting in 
increased matrix pH, which lowers the ΔΨm and prevents further uptake of Ca
2+(40). 
Uptake of substantial amounts of Ca2+ therefore requires buffering of matrix pH (to 
allow regeneration of the ΔΨm) as well as buffering of matrix Ca
2+ (to prevent the 
buildup of a Ca2+ concentration gradient)41-43. Buffering of matrix pH is achieved by the 
simultaneous uptake of protons and anions via diffusion of the undissociated acid 
through the IMM (as in the case of acetate), of CO2 (which then regenerates bicarbonate 
and H+ in the matrix) or through transport proteins (like the H+–Pi symporter)44. The 
buildup of a Ca2+ concentration gradient may be prevented by the cotransport of Pi. 
Indeed, under physiological conditions the parallel accumulation of Pi and Ca2+ leads to 
the formation of a Ca2+/Pi complex in the matrix which effectively buffers matrix free 
[Ca2+]45. However, the [Ca2+] inside the mitochondrial matrix is not exclusively dictated 
by ΔμCa, but is rather governed by a kinetic steady state between Ca2+ influx via the 
uniporter and Ca2+ efflux by antiporters (Na+/Ca2+ and H+/Ca2+ exchanger) that extrude 
Ca2+ from the matrix  using the concentration gradients of H+ and Na+. The Na+/Ca2+ 
exchanger NCLX, which mediates Ca2+ efflux with a stoichiometry of 3 Na+- 1 Ca2+, has 
been recently identified at the molecular level46, whereas the Na+-insensitive Ca2+ 
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extrusion pathway via a putative H+/Ca2+ exchanger has been studied only functionally 
in isolated mitochondria and has a predicted stoichiometry of 3 H+-1 Ca2+ (47).  
 
 
 
Figure 6. Schematic representation of mitochondrial Ca
2+
 uptake and efflux mechanisms. Ion fluxes are indicated by 
arrows. Red arrow, Ca
2+
; blue arrow, H
+
; yellow arrow, Na
+
. ETC: electron transport chain; NCLX: Na
+
/Ca
2+
 exchanger; 
HCX: H
+
/Ca
2+
 exchanger; PTP: permeability transition pore; UCP2/3: uncoupling protein 2/3; VDAC: voltage-dependent 
anion channel; IMS: intermambrane space; MCU: mitochondrial Ca
2+
 uniporter; MICU1: mitochondrial Ca
2+ 
uptake 1; 
modified from
48
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2.3 The problem of Ca2+ overload: a constant threat for mitochondria  
The coupling of Ca2+ uptake with Ca2+ efflux in energized mitochondria on distinct 
pathways allows the regulation of both cytoplasmic and matrix [Ca2+]. However, a 
kinetic imbalance is apparent because the Vmax of the MCU is about 1400 nmol Ca
2+ per 
mg protein per min while the combined Vmax of the efflux pathways is about 20 nmol 
Ca2+per mg protein per min. What is the reason for such an imbalance? The rate of Ca2+ 
uptake via the MCU is a steep function of extramitochondrial [Ca2+]49. If mitochondria 
could release Ca2+ at a comparable rate this would increase extramitochondrial [Ca2+], 
stimulate Ca2+ uptake by the MCU and increase overall Ca2+ cycling resulting in energy 
dissipation50. Thus, net Ca2+ efflux through stimulation of the efflux pathways would 
have a high energetic cost for the cell, which can be avoided with the previously 
described low Vmax and early saturation of the efflux pathways. However, this energy-
saving strategy exposes mitochondria to another dangerous problem. According to the 
above described kinetic model, increase of extramitochondrial Ca2+ goes along with 
matrix
IMS
ΔΨ -180mV
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increase of matrix Ca2+ when the rate of Ca2+ uptake exceeds that of the efflux 
pathways and thus mitochondria are constantly exposed to the danger of Ca2+ overload.  
To prevent this scenario mitochondria need a system to achieve transient, fast and 
regulated Ca2+ release in situations of high matrix [Ca2+]. It was hypothesized that this 
mechanism could be provided by transient openings of the PTP and there is more and 
more evidence that this plays a relevant role in in vivo Ca2+ homeostasis and signalling 
processes, as will be discussed more in detail below.  
 
3 The permeability transition pore (PTP) 
The mitochondrial permeability transition (PT) describes a process of Ca2+-dependent, 
regulated increase in the permeability of the inner mitochondrial membrane to solutes 
with molecular masses below approximately 1500 Da. This event, which plays a major 
role in cell death, is due to the opening of the mitochondrial PTP, a high-conductance 
inner membrane channel. The PTP was discovered and studied mostly in mammals 
where it was shown to play a role in different cellular processes, depending on the open 
time of the channel. PTP opening causes collapse of ΔΨm and Ca
2+ release through the 
pore itself, an event that for short open times may be involved in physiological Ca2+ 
homeostasis51 and might play a role in cell signaling52. Prolonged opening of the PTP, on 
the other hand, causes stable depolarization, loss of ionic homeostasis, depletion of 
pyridine nucleotides and respiratory inhibition. During the PT ions and osmotically 
active molecules (up to 1500 Da) can enter the mitochondria and consequently lead to 
influx of water into the matrix and thus mitochondrial volume increase. Matrix swelling 
in turn can lead to rupture of the OMM, release of apoptogenic proteins such as cyt c 
and cell death via apoptosis or necrosis depending on a variety of additional factors, 
among which cellular ATP and Ca2+ levels play a major role53. For a long time the PTP 
was considered to be an in vitro artifact of little pathophysiological relevance. However, 
the role of the PTP in disease has been reevaluated in the context of both programmed 
and accidental cell death39 and there is increasing evidence that it might function as a 
Ca2+ release channel in physiological Ca2+ homeostasis, as will be discussed below. 
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Figure 7. Mechanisms of mitochondrial permeabilization and release of intermembrane space proteins due to the 
opening of the permeability transition pore. Opening of the permeability transition pore (PTP) can be triggered by 
different stimuli and results in loss of mitochondrial membrane potential (Δψm), decreased ATP production and entry 
of solutes and water into the mitochondrial matrix. This causes mitochondrial swelling, outer mitochondrial 
membrane (OMM) rupture and release of apoptogenic proteins, such as cytochrome c (cyt c) from the 
intermembrane space into the cytosol. Cyt c in turn leads to formation of the apoptosome and subsequent activation 
of the caspase cascade, thus inducing cell death. Cyp-D: Cyclophilin D; modified from
54. 
 
3.1  Features and regulation of the PTP in mammals 
Most classical studies of the PT were carried out in mitochondria obtained from 
mammalian cells or tissues. These studies allowed a thorough characterization of the 
functional properties and regulation of the putative channel, but its molecular nature 
remains still elusive. The transition between the “open” and “closed” state of the PTP 
can be modulated by many different compounds, ions or conditions. These PTP 
effectors can be subdivided into inducers, that increase the probability of the pore to 
open; and inhibitors, that increase the probability of the pore to close. Perhaps the 
single most important factor, which is essential for opening of the PTP and therefore is 
called a “permissive factor”, is matrix Ca2+.  Importantly, all the other divalent metals, 
such as Mg2+, Mn2+ and Sr2+ instead decrease the PTP open probability. Another 
important modulator of the PTP is matrix pH, with an optimum for PTP opening at pH 
7.4. More basic as well as more acidic pH desensitizes the PTP to opening55. The PTP is a 
voltage-dependent channel, in the sense that a decrease in ΔΨm favors PTP opening, 
whereas a high inside-negative ΔΨm tends to stabilize the pore in the closed 
conformation56. This led to the hypothesis that a specific sensor, which is able to 
solutes 
and water
cyt c
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perceive the threshold potential necessary to open the PTP, does exist. Many PTP 
modulators appear to modify the threshold potential, bringing it closer (inducers) or 
moving it further away (inhibitors) from the resting potential50. Thus, an inducer brings 
the threshold potential needed for PTP opening closer to the resting potential, and 
makes mitochondria more susceptible to PTP opening even after slight depolarizations. 
Inhibition of PTP can also be observed with bongkrekate57, whereas atractylate opens 
the pore58. Since atractylate and bongkrekate are selective inhibitors of the adenine 
nucleotide translocase (ANT), these results led to the suggestion that the PTP may be 
entirely or partially formed by the ANT59, an issue that will be discussed below.  
The PTP can be directly regulated by electron flux within complex I of the respiratory 
chain, with an increased open probability when flux increases60. This led to the 
discovery that quinones can modulate the PTP, with some of them acting as inhibitors 
(such as ubiquinone 0 (Ub0) or decylubiquinone) and others as inducers (such as 2,5-
dihydroxy-6-undecyl-1,4-benzoquinone). A third class of PTP-inactive quinones (such 
as ubiquinone 5) are able to counteract the effects of both inhibitors and inducers. 
However, despite a large number of studies, the exact relationship between quinone 
structure and effect on the pore remains unsolved61. 
Opening of the PTP is strongly favored by an oxidized state of the pyridine nucleotides  
NADH and NADPH as well as of critical thiol groups at distinct matrix or membrane 
sites. Both of these effects can be reversed by reducing agents62, 63. The interconversion 
between dithiol and disulfide groups correlates with the redox state of glutathione, 
suggesting that there is a redox equilibrium between the dithiols and matrix 
glutathione. This finding explains the effect of thiol reacting agents such as N-
ethylmaleimide (NEM)64, 65 and monobromobimane66 on the pore. 
Inorganic phosphate (Pi) is a powerful PTP inducer in mammalian mitochondria, 
whereas it has an inhibitory effect in yeast mitochondria. As Pi is also taken up following 
Ca2+ uptake into the matrix, where it leads to the formation of a Ca2+-Pi complex, an 
increased threshold of the PTP to Ca2+ should be expected when Pi is present, due to its 
lowering effect on free matrix [Ca2+]. The unexpected inducing effect of Pi on the PTP 
has been explained by the fact that an increase of Pi also produces a decrease in matrix 
free [Mg2+] (a PTP inhibitor), as well as buffering of matrix pH at ~7.2, and it may 
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generate polyphosphate67, all of which would favor PTP opening. Recently, our group 
demonstrated that Pi can also act as an inhibitor of the PTP in case of genetic ablation 
of the matrix peptidyl-prolyl-cis-trans-isomerase (PPIase) Cyclophilin D (Cyp-D) or its 
displacement from the pore by its specific inhibitor Cyclosporin A (CsA). We 
hypothesized that Cyp-D might mask a Pi-regulatory site, which becomes only 
accessible when Cyp-D is detached from the pore68.  
 
 
Figure 8. Modulation of the permeability transition pore by Cyclophilin D and Phosphate in mammalian 
mitochondria. The permeability transition pore (PTP) displays a higher probability of opening (right) when it binds to 
Cyclophilin D (Cyp-D); treatment with Cyclosporin A (CsA) displaces Cyp-D and unmasks a cryptic site for inorganic 
Phosphate (Pi) (center); if the Pi concentration is sufficiently high, Pi binding decreases the probability of pore opening 
(left), in a reaction that can be readily reversed if the Pi concentration decreases; from
69. 
 
Opening of the PTP is inhibited by the immunosuppressive drug CsA70 through the 
binding to its matrix target CyP-D. CsA acts on Cyp-D by inhibiting its PPIase activity, 
but whether this is essential for the modulating effect of Cyp-D on the PTP is still 
unclear71. Likewise (and at variance from immunosuppression), the effect of CsA does 
not involve inhibition of calcineurin72. However, CsA cannot be regarded as a true PTP 
blocker but rather as a desensitizer, as pore opening still occurs in presence of CsA, even 
if the threshold Ca2+ needed for PTP opening increases two to three-fold. Furthermore, 
sensitivity to CsA highly depends on the expression level of Cyp-D and is thus tissue- 
and cell type-specific. Tissues or cell lines expressing low levels of Cyp-D were shown to 
be less sensitive to CsA but more sensitive to another potent PTP inhibitor, rotenone73. 
On the other hand, high expression levels of Cyp-D correlate with a high sensitivity to 
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CsA and a low sensitivity to rotenone. Inhibition of the PTP by rotenone requires Pi in a 
striking analogy with the effect of CsA, suggesting that both might act on the same 
binding site. Thus, inhibition of complex I by rotenone and detachment of Cyp-D by CsA 
might affect the PTP through a common mechanism73.  
 
 
Figure 9. Modulators of the permeability transition pore in mammals. All modulators are grouped in inhibitors which 
promote the closed and inducers which promote the open state of the pore, signs denote transmembrane electrical 
potential, Ub0: Ubiquinone 0, Cyp-D: Cyclophilin D, CsA: Cyclosporin A, ΔΨm: mitochondrial membrane potential; 
modified from
74
. 
 
3.2 Structure 
Many hypotheses on the molecular nature of the PTP have been put forward over the 
years. Based on many pharmacological studies, the PTP has been supposed to be a 
multiprotein-channel created by defined components.  
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VDAC: (voltage dependent anion channel, located in the OMM). Several data led to the 
hypothesis that VDAC is a component of the PTP. Purified VDAC when incorporated in 
phospholipid bilayer membranes forms channels with size and electrophysiological 
properties similar to those of the PTP75, 76. In addition it has been found that VDAC can 
be modulated by some of the stimuli that regulate the PTP, e.g. Ca2+, NADH, 
glutamate77-79, and binding of hexokinase II80. In mammals there are three VDAC 
isoforms (VDAC 1, 2 and 3), and each of them is able to form channels when 
incorporated in phospholipid bilayers81. However, characteristics of permeability 
transition have been studied in VDAC1-/- mice, but the properties of the PTP in mutants 
and wild-type mice were identical82. Studies in cells lacking all of the three isoforms 
finally led to the conclusion that VDAC is not essential for the mitochondrial PT83. 
 
ANT: The adenine nucleotide translocator was supposed to be a component of the 
pore, as the PTP can be modulated by inhibitory ligands of ANT and by adenine 
nucleotides themselves84. Studies in ANT knock-out mitochondria isolated from mouse 
liver, however, showed that ANT as well is not essential for PTP formation. ANT-/- 
mitochondria undergo a PT which is Ca2+- and oxidant-dependent as well as CsA-
sensitive. This indicates that ANT is neither the binding partner of Cyp-D nor it is the 
target for the oxidants85. Furthermore, isolated hepatocytes of wild-type and ANT 
knock-out mice show an identical response to death receptor-mediated activation of 
apoptosis. Thus, experimental data based on genetic ablation of the relevant proteins 
support the conclusion that also ANT is not an essential component of the PTP. 
 
Phosphate carrier: The phosphate carrier (PiC) is a member of the mitochondrial 
carrier family and promotes the transport of Pi across the IMM. Uptake of Pi into the 
mitochondria is essential for the production of ATP from ADP. Different studies 
hypothesized a role for PiC in the PTP composition due to the fact that some inhibitors 
of the PTP such as NEM65, Ub0
86 and Ro 68-340087, are also PiC inhibitors88, 89. However, 
these studies were performed with de-energized mitochondria incubated in the 
presence of 40 mM Pi, conditions that are far from physiological. Thus, it is 
questionable how relevant the obtained results are to an in vivo situation. Another 
critical point is the inseparable relationship between Ca2+ and Pi uptake in 
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mitochondria. Inhibition of PiC by NEM in respiring mitochondria blocks Pi uptake and 
consequently limits Ca2+ uptake to amounts that may be below the threshold level for 
PTP opening42. Thus, the effect of PTP inhibition due to decreased Pi or decreased Ca2+ 
uptake is hard to sort out. Furthermore, the ubiquinone analogues Ub0 and Ro 68-3400 
desensitize the PTP to Ca2+ even when Pi is replaced by arsenate or vanadate68. 
Whether the PiC is a component of the PTP should be addressed by knock-out 
approaches as used for studying the role of ANT and VDAC. A recent attempt to 
elucidate the role of PiC in pore formation by siRNA down-regulation of both splice 
variants (PiC-A and PiC-B) failed, since maximal knock down efficiency was 65-80% and 
the remaining protein was sufficient to maintain maximal rates of Ca2+ uptake without 
any detectable decrease in PTP opening89. 
 
Cyclophilin D: The regulatory role of the mitochondrial peptidyl-prolyl-cis-trans-
isomerase Cyp-D on the PTP has been discovered through the finding that the 
immunosuppressant drug CsA, a potent inhibitor of the intrinsic apoptotic pathway, 
also inhibits the PTP at concentrations very similar to those needed to inhibit the 
enzymatic activity of Cyp-D72, 90. Several genetic studies have demonstrated that Cyp-D 
is a regulator of the PTP, sensitizing it to Ca2+, rather than being a component of the 
pore68, 91, 92. Further details on structure and function of Cyclophilins and in particular 
Cyp-D will be provided in chapter 4. 
 
Additional proteins may play a regulatory role on the PTP. Amongst these the anti-
apoptotic and pro-apoptotic proteins of the Bcl-2-family in the OMM93, mitochondrial 
creatine kinase (which produces ATP from ADP by converting creatine phosphate to 
creatine)94, mitochondrial hexokinase (which catalyze the first step of glycolysis)95, 96 
and the peripheral benzodiazepine receptor (PBR or TSPO), located in the OMM and 
involved in steroidogenesis97. 
 
3.3 The PTP as a Ca2+ release channel 
Besides its well accepted role in cell death induction, the PTP was hypothesized to be a 
Ca2+ release channel whose transient opening protects mitochondria from Ca2+ 
overload. This idea could be corroborated through recent studies in isolated 
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cardiomyocytes, adult cortical neurons and Cyp-D KO mice.  In 1992, R. Altschuld et al. 
demonstrated that CsA significantly increases net Ca2+ uptake and decreases Ca2+ efflux 
in isolated cardiomyocytes, without having any impact on cell morphology or viability98. 
The effect of CsA was concentration dependent and specific to mitochondria, as ATP-
dependent Ca2+ uptake by the sarcoplasmatic reticulum was not affected. This was the 
first piece of evidence that the PTP might contribute to Ca2+ cycling in the mitochondria 
of functional cardiomyocytes and that reversible pore opening may be a normal process 
in heart cells. However, a direct role for the PTP in regulation of mitochondrial total 
Ca2+ in situ remained controversial, as Eriksson et al. demonstrated that fluxes of Ca2+, 
Mg2+ and adenine nucleotides in perfused rat livers following hormonal stimulation 
were unaffected by CsA99. The authors concluded that regulation of mitochondrial ion 
and metabolite homeostasis is independent of the PTP. Two recent publications based 
on a knock-out mouse model lacking the Ppif gene encoding for the mitochondrial Cyp-
D do provide clear support for a role of the PTP in Ca2+ homeostasis100, 101. Barsukova et 
al. treated adult cortical neurons from wild type and Ppif−/− mice with either ATP (to 
activate P2Y purinergic receptors) or with depolarizing concentrations of KCl (to open 
plasma membrane voltage-dependent Ca2+ channels), and demonstrated that both 
stimuli cause a robust increase of both cytosolic and mitochondrial [Ca2+] that is 
indistinguishable in neurons of the two genotypes101. Application of the two stimuli 
together, however, resulted in much higher levels of mitochondrial [Ca2+] in the Ppif−/− 
neurons, suggesting that the threshold for PTP activation had been reached in the wild 
type but not in the Cyp-D null mitochondria in situ. The higher resistance to 
mitochondrial Ca2+ overload and thus the capacity to blunt in vivo cytoplasmic Ca2+ 
increases might explain the neuroprotective effect of Cyp-D ablation in many 
neurodegenerative disease models and underlines the high physiological importance of 
transient, rather than persistent PTP opening102-104. The implication of Cyp-D and the 
PTP in pathologic conditions in vivo was further investigated by Elrod et al. Cyp-D KO 
mice were more susceptible to cardiac hypertrophy, fibrosis and reduction in 
myocardial function upon treatment with stimuli such as transaortic constriction, 
overexpression of Ca2+/calmodulin-dependent protein kinase IIδc and swimming 
exercise100. Myocardial dysfunction was not due to altered cell viability indicating an 
additional role of the PTP beyond cell death induction. Indeed, the authors showed that 
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heart mitochondria lacking Cyp-D had higher resting Ca2+ levels resulting in metabolic 
alterations such as activation of Ca2+-dependent dehydrogenases and increased glucose 
oxidation, thus limiting the heart’s ability to maintain contractility during stress 
situations. This was the first in vivo study demonstrating that the PTP is an important 
regulator of Ca2+ homeostasis and of signaling events critically involved in metabolic 
adaptation to disease states such as heart failure. For further discussion and more 
detailed analysis of this topic see Publication 3. 
 
3.4 The PTP in other species: a channel conserved through evolution? 
Classical studies on the PTP were carried out mostly in mitochondria obtained from 
mammals, although permeability changes have also been described in yeast 
mitochondria105-109. However, due to the increasing interest on the PT in cell death, 
studies have emerged also in mitochondria from other organisms, e.g. plants110-114, 
fish115, 116 and amphibians117, 118. Until recently, though, it was not clear whether the 
permeability changes observed in these organisms can be ascribed to the same 
molecular events. Our recent findings in Drosophila might bridge the gap between the 
pore of yeast and that of mammals, and support our proposal that channels in different 
species actually possess unifying features119, as will be described below.  
 
3.5  Ca2+ transport and PT in yeast mitochondria 
Cell signaling roles of Ca2+ are less developed in lower eukaryotes, explaining why 
mitochondria may be less critical in the maintenance of Ca2+ homeostasis. In addition, 
ATP production in yeast seems to be independent of the regulation of Ca2+(120). This can 
be explained by the fact that mitochondria from most yeast strains do not possess a 
rapid Ca2+ uptake system as the MCU106, 121 (although there are strain-specific 
differences, as Endomyces magnusii does have a Ca2+ uniporter122) or a Na+-stimulated 
Ca2+ release pathway as NCLX. Nevertheless, they do contain a mitochondrial Ca2+:2H+ 
antiporter extruding Ca2+ from the matrix, which is highly active in presence of free 
fatty acids123, suggesting that matrix Ca2+ may serve some regulatory role.  
Yeast mitochondria also possess a fast Ca2+ release channel called yeast mitochondrial 
unselective channel (YMUC), which can be opened by respiration or nucleotides and has 
 
37 INTRODUCTION 
similar electrophysiological properties as the mammalian PTP105-109, 124. For a long time 
yeast was considered to be a poor model for studying the PTP, as the regulation of this 
channel seemed to be too different, particularly because it is inhibited rather than 
activated by Pi, and insensitive to CsA107. Several new results, however, suggest that the 
PTP of yeast and mammals may be closer than previously thought. One issue concerns 
the Ca2+-dependence of YMUC in the presence of the Ca2+ ionophore ETH129, which 
allows electrophoretic matrix Ca2+ accumulation in yeast mitochondria106. A recent 
study shows that in optimized conditions, i.e. using low concentrations of Pi (an 
inhibitor of the yeast pore), the opening of the channel becomes Ca2+-dependent109. The 
opposing effects of Pi (which is an inducer of the mammalian PTP and an inhibitor of 
the yeast pore) could be recently explained in a study showing that Pi may become an 
inhibitor in mammalian mitochondria that are treated by CsA or in which Cyp-D had 
been genetically ablated68. We suppose that Cyp-D is masking an inhibitory Pi binding 
site which becomes accessible only when Cyp-D is removed. Thus, we hypothesize that 
the yeast mitochondrial cyclophilin CYP3125 may not be able to bind the PTP, and 
thereby to hinder the binding site for Pi. This scenario would explain the inhibitory 
function of Pi as well as the lack of CsA-sensitivity in yeast. Additional points are the 
lack of effect of several inducers of the mammalian PTP like carboxyatractylate 
(inhibitor of the ANT), ligands of the PBR, and prooxidants in yeast107. However, some of 
these differences might depend on experimental conditions as e.g. the dithiol 
crosslinker phenylarsine oxide, one of the most important PTP-inducers, is able to 
sensitize the yeast pore to Ca2+(126). Based on these observations, we believe that the 
yeast and mammalian PT may be the expression of very similar events, although they 
differ in modulation through mechanisms that will be fully understood only after the 
molecular nature of the PTP is defined. 
For further description of PT in other species and comments on the conservation of the 
PTP during evolution see Publication 2. 
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4  Cyclophilins 
The cyclophilins are a family of highly conserved PPIases with a crucial role in protein 
folding. The peptide bonds of any protein can exist in two different isomeric forms, cis 
or trans. Protein folding as well as refolding processes following cellular membrane 
traffic require isomerization and the interconversion between the cis and the trans form 
of prolines relative to the nascent polypeptide chain is catalyzed by cyclophilins and 
other PPIases. All cyclophilins share a common domain of about 109 amino acids, the 
cyclophilin-like domain (CLD), surrounded by domains unique to each member of the 
family that are associated with subcellular compartmentalization and functional 
specialization127. All cyclophilins can bind the immunosuppressant drug CsA. The 
cytoplasmic Cyclophilin A (Cyp-A) is the main intracellular receptor for CsA128. The 
immunosuppressive action of CsA is carried out via a ternary complex between CsA, 
Cyp-A and calcineurin, a calcium-calmodulin-activated serine/threonine-specific protein 
phosphatase. The CsA-Cyp-A complex inhibits calcineurin preventing 
dephosphorylation, hence nuclear translocation of the nuclear factor of activated T cells 
(NFAT), thus preventing the transcription of genes encoding cytokines129.  
 
4.1 Cyclophilin D 
Cyp-D, which in the mouse is encoded by the Ppif gene, possesses a mitochondrial 
targeting sequence and is imported into the mitochondrial matrix upon translation. 
Cyp-D has a series of binding partners inside mitochondria. In the matrix it interacts 
with a complex chaperone network involving Hsp90 and its related molecule TRAP-1130. 
Capturing of Cyp-D to this complex makes it no longer available for binding to, and 
inducing, the PTP, which might be a strategy to protect from cell death. Treatment of 
tumor cells with shepherdin, an Hsp90 antagonist, leads to replacement of Cyp-D from 
the Hsp90–TRAP-1–Cyp-D complex and selective killing of tumor cells130. Another 
target of Cyp-D is the FOF1-ATP synthase, as recently documented in bovine heart and 
liver mitochondria131. Giorgio et al. demonstrated that Cyp-D binds to the lateral stalk of 
the enzyme, forming a complex with the OSCP, b, and d subunits, and that this binding 
is favored by Pi. Association of Cyp-D to the FOF1-ATP synthase decreases the ATPase 
activity while treatment with CsA increases the latter and displaces Cyp-D from the 
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ATP synthase. A recent study also demonstrated a CsA-sensitive interaction of Cyp-D 
with the anti-apoptotic protein Bcl2132.  
Cyp-D binds to the IMM in a process that is associated with PTP opening, promoted by 
increased intramitochondrial levels of Ca2+ and/or reactive oxygen species and inhibited 
by CsA. The first pharmacological tool used to demonstrate the relationship between 
Cyp-D and the PTP was CsA. Later this interaction was confirmed by other Cyp-D 
ligands such as sanglifehrin A, NIM-811, Debio-025 and antamanide133-136. However, only 
after the generation of Ppif-/- mice lacking Cyp-D, a final evidence for Cyp-D in PTP 
regulation could be provided. Several studies analyzed fibroblasts, thymocytes and 
hepatocytes isolated from Ppif-/- mice and evaluated in particular the response to 
different apoptotic stimuli91, 102, 137, 138. Basso et al. showed that the PTP in Ppif-/- 
mitochondria still forms, consistent with its role as a pore regulator, but not as a 
structural component.  The propensity of PTP opening in Cyp-D null mitochondria is 
strikingly reduced in that the opening requires about twice the Ca2+ load necessary to 
open the PTP in wild type mitochondria. PTP opening in Ppif-/- mitochondria was 
insensitive to CsA, as expected. Studies in cells lacking Cyp-D showed that they were 
more resistant to oxidative stress and increased cytoplasmic Ca2+(102). On the other 
hand, increased Cyp-D expression in a neuronal cell line139 and in mitochondria from rat 
hearts with volume overload-induced compensated hypertrophy140 were more 
susceptible to PTP opening and cell death. Recently, Basso et al. have shown that the 
desensitizing effect of Cyp-D ablation or CsA treatment on the pore is only present 
when Pi is used, but not when the latter is replaced by its analogues arsenate or 
vanadate. As already mentioned, these results suggest that when Cyp-D does not bind 
to the PTP (because of genetic ablation or of the binding to CsA) Pi can bind to an 
inhibitory site on the pore thereby delaying pore opening68. 
There is a striking analogy between the regulation of the PTP and the ATP synthase by 
Cyp-D and CsA. Indeed, Pi favors binding of Cyp-D to ATP synthase and PTP opening, 
while CsA promotes Cyp-D unbinding from the ATP synthase and PTP closure. Whether 
this is due to a link between the two processes is currently under investigation in our 
laboratory. Our recent studies have shown that the PTP might form from dimers of the 
ATP synthase (Giorgio et al, submitted). 
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5 The fruit fly Drosophila melanogaster 
The ecdysozoan arthropod Drosophila melanogaster belongs to a sub-species of the 
Drosophilidae, dipteran insects found all over the world. The species is known generally 
as the common fruit fly. The life cycle of Drosophila varies with temperature, as is the 
case for many ectothermic species. At 25°C the developmental time (egg to adult) is 
about 10 days.  Females lay about 400 eggs into rotting fruit or other suitable material. 
The eggs, which are about half a millimeter long, hatch after about one day into a 
worm-like larva. The larva grows for about 4 days, molting at day 1, day 2, and day 4 
after hatching (first, second and third instar larva). After another two days the larva 
molts one more time to form an immobile pupa and undergoes a four-day-long 
metamorphosis, in which the body is completely remodeled to give rise to the adult 
winged form. The life cycle is concluded with the hatching from the pupal case after 
which the fly becomes fertile within about 12 hours.  
 
Figure 10. Life cycle of Drosophila melanogaster. One day after fertilization the larva hatches. First, second, and third 
instar are larval stages, each of them ending with a molt. In the pupal stage most of the larval tissues are destroyed 
and replaced by adult tissues derived from the imaginal discs that were growing in the larva. Times are indicative for 
the life cycle of flies maintained at 25°C; modified from
141
. 
pupa
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 Since during evolution arthropods separated from vertebrates more than 600 million 
years ago142, 143, Drosophila might be supposed to be very different from humans with 
respect to genetics and cellular pathways. However, comparative analysis of the 
genome of Drosophila and humans revealed striking similarities in the structural 
composition of individual genes144 and Drosophila quickly became an important tool for 
genetic, molecular and behavioral studies.  
 
5.1 Drosophila as a model organism 
Since T.H. Morgan in 1910 demonstrated the chromosome theory of heredity in the 
fruit fly Drosophila, this organism has played an important role in the development of 
modern biology, in particular in the area of genetics. Today it is one of the most 
important model organisms in studies of development and differentiation145, aging146, 
cell cycle147, transcriptional and translational control148, signaling pathways149, sensorial 
perception150 , neurodegenerative diseases151 and circadian rhythms152.  
Moreover Drosophila melanogaster has been one of the first organisms to be sequenced 
in its entirety153, and a database with all nuclear and mitochondrial encoded genes is 
available154. The Drosophila genome contains a large number of human orthologs, 
which include conserved molecules and pathways of key cellular processes155. These 
findings quickly made Drosophila an important system to model human diseases156. 
Research projects focused on neurodegenerative diseases157, cancer158, cardiac 
pathologies159, age-associated dysfunction160 and recently also on mitochondrial 
diseases161-163 have emerged.  
Compared to higher organisms Drosophila offers some attractive features as a model 
organism; these are especially suited for studying complex biological processes. 
Drosophila is ideally tractable at the genetic, biochemical, molecular and physiological 
levels. First of all the flies can be easily maintained in large numbers in stocks and 
populations without specialized instrumentation. Drosophila has a short life-cycle 
resulting in the production of a large number of progeny over a short, 10-day 
generation period155. Other model organisms such as the mouse require a longer, 21-
day gestation time and produce a smaller number of progeny. For the purpose of 
genetic screens, Drosophila provides two benefits in that its genome is comprised of 
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only 4 pairs of chromosomes, as opposed to 16 in the yeast strain Saccharomyces 
cerevisiae, or 23 in humans, thus simplifying genetic inheritance. The second advantage 
is that mutants can be created quite easily by molecular techniques using P-element 
transposons164, site specific recombination to knock-in and knock-out specific genes, or 
RNA-interference to knock-down gene expression165. In recent years many different 
tools to trigger gene expression or repression have been developed. Furthermore, the 
use of X-rays and other mutagenic agents makes it possible to generate large 
collections of mutant stocks. Several key features of Drosophila, such as the compound 
eye, provide unique methods for studying mutational effects by simple visual 
observation of the resulting phenotype155. Thus, Drosophila provides an excellent model 
organism through the compromise between simple cultivation, genetics and 
phenotypic scoring, while key cellular processes are evolutionary conserved. Also with 
respect to my PhD project concerning Ca2+ transport and permeability transition in 
mitochondria, Drosophila seemed to be an interesting alternative to the mammalian 
models, usually employed in these studies.   
 
5.2 Drosophila cell lines 
Despite the numerous advantages which Drosophila offers in various research fields, 
using whole organisms as basic material for experiments has some limits. For example, 
some mutations can have lethal effects in adults and therefore it becomes impossible 
to compare mutant with wild type flies. Another disadvantage can be the heterogeneity 
of the fully differentiated cell-types in the adult flies and thus an uneven response to 
stimuli. Thus, for some research projects it becomes necessary to isolate specific 
tissues, cells or organelles which, due to the size of the flies, can be a laborious and 
time-consuming work which often results in an insufficient yield. This is especially the 
case when mutations have an impact on growth and viability of the flies, and therefore 
the number of adults is limited. Thus, in recent years cultured Drosophila cell lines 
emerged as an important tool in different research fields. The cells are in most cases 
derived from embryonic states, e.g. Schneider (S2) cells166, composed of a variety of 
tissue precursors and are therefore undifferentiated. However, also tissue-specific 
imaginal disc167 and CNS-derived168 cell lines have been established. All these cell lines 
greatly facilitate biochemical studies and resolve the yield problem mentioned above, 
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since they provide virtually unlimited amounts of homogenous material. With specific 
respect to the aim of my PhD Thesis, they proved useful to obtain a sufficient amount 
of mitochondria to perform studies on bioenergetics, Ca2+ fluxes and permeability 
transition. Moreover, especially with new techniques like RNA-interference169, different 
mutant cell lines can be generated, bypassing also the lethal effects of some mutations 
on adult flies. Furthermore Drosophila cell lines have been successfully used in 
heterologous protein expression studies and stable cell lines constitutively or 
inductively expressing the desired protein could be created170-172. For the study of my 
PhD Thesis I used the cell line S2R
+(173) which is derived from late embryonic stages (20-
24h old embryos), and differs from its ancestor (S2) in that it has the ability to adhere to 
tissue culture dishes. The primary culture was prepared and immortalized by I. 
Schneider (1972) from enzymatically disaggregated embryos. For detailed information 
on the exact procedure see166. Although Drosophila cell lines can be cultured in a similar 
way as mammalian cell lines, some important differences should be considered174. 
Drosophila cells should be grown at 25°C and need no CO2 buffering, the ideal gas being 
ordinary air. Moreover, they do not show the phenomenon of “contact inhibition”, 
displayed by mammalian cells. After forming a monolayer on the substrate, Drosophila 
cells continue to proliferate, building more than one layer or growing in suspension. 
 
5.3 Drosophila mitochondria in research  
As soon as it became obvious that most of the genes implicated in human diseases have 
at least one fly homolog175, Drosophila became a powerful tool to elucidate the 
molecular and cellular mechanisms that underlie these disorders. Most research 
projects concerning mitochondria from Drosophila are focused either on the 
mitochondria-induced mechanisms of aging or on the mitochondrial involvement in 
neurodegeneration with the aim to model human neurodegenerative disorders, such as 
Alzheimer’s, Parkinson’s and Huntington’s disease.  
Drosophila and aging 
The mitochondrial electron transport chain is one of the primary sources of reactive 
oxygen species (ROS) within cells, as ROS are by-products of respiration. While ROS 
may have important roles in cell functions such as cell signaling, it has been discovered 
 
44 
that high levels of ROS also cause cellular damage176. Since the early fifties it was 
hypothesized that the accumulation of molecular damage caused by ROS contributes 
to the functional decline during the aging process177. A number of studies in Drosophila 
confirmed an important role for mitochondrial ROS in modulating lifespan. Those 
studies engineered flies with increased oxidative stress response by the adult-specific 
overexpression of the mitochondrial Mn-Superoxide Dismutase (MnSOD), which led to 
an increased lifespan178. Another approach to reduce oxidative stress was the reduction 
of mitochondrial ROS production, which was achieved by the expression of the human 
uncoupling protein 2 (hUCP2) in adult Drosophila neurons, again leading to the 
extension of lifespan179. However, it cannot be excluded that the reduction of ROS 
increases lifespan indirectly through changes in cell signaling or gene expression. Other 
studies in Drosophila demonstrated age-related decreases in respiratory chain activity 
and changes in mitochondrial structure180, 181. These observations can be explained 
either by the damaging effect of ROS or by the decline in expression of genes that are 
important for the electron transport chain with aging182.   
Drosophila and neurodegeneration 
Neurodegenerative diseases are a large group of disorders of the nervous system, 
characterized by the progressive selective loss of neuronal subtypes such as 
dopaminergic or motor neurons. Mitochondrial abnormalities have been documented in 
neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and Huntington’s 
diseases and amyotrophic lateral sclerosis and several studies have demonstrated that 
mitochondrial impairment plays an important role in the pathogenesis of this group of 
disorders (for an overview of the major findings in recent years see183, 184 and185). A 
suitable model organism to study human neurodegenerative diseases should have 
homologues to the genes mutated in the human disorder and should possess 
neurobiological cellular processes (such as synapse formation and neuronal 
communication) and neurobiological bases of behavior (such as sensory perception, 
aspects of learning and memory formation) that are similar to those found in humans. 
All of these criteria are fulfilled by Drosophila, where two approaches are commonly 
used. First, the expression of a human disease gene in its wild type or mutant form in a 
Drosophila tissue, usually the eye, and assessment of the corresponding phenotype186. 
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Second, loss or gain of function analysis of the Drosophila homolog of the human 
disease gene and assessment of the associated phenotypes165. A third possibility is the 
screen of compounds in the already established Drosophila disease model in order to 
pick out those that ameliorate the phenotype. This approach was successfully used in 
fly models of adult-onset, age-related neurodegeneration and led to the complete 
rescue of disease-related phenotypes187. Studies in the last two decades brought up 
reliable Drosophila models for Alzheimer’s188, 189, Parkinson’s190, 191 and motor neuron 
diseases192, as well as for trinucleotide expansion diseases193, such as ataxias194 and 
Huntington’s disease195.  
 
5.4 Involvement of Drosophila mitochondria in apoptosis 
In mammalian cells the key step in mitochondrial-induced cell death occurs when the 
OMM permeabilizes and several apoptogenic proteins, including cyt c, Smac/DIABLO, 
AIF and endoG are released from the mitochondrial IMS29. In mammals, the subsequent 
activation of caspases is dependent on cyt c-induced apoptosome formation196. The 
process of MOMP is highly regulated by members of the Bcl-2 family. Like worms and 
mammals, the Drosophila genome encodes at least two Bcl-2 family members197. 
Sequence analysis revealed that Drosophila possesses seven members of the caspase 
family198, which can be divided into initiator and effector caspases. The essential 
apoptotic initiator caspase is named Dronc, and like mammalian caspase 2 and 9 it 
interacts with Dark, the fly homolog of Apaf-1199. Consistently, Dronc can function as an 
initiator caspase to cleave and activate the effector caspase Drice200. 
However, conclusions about apoptotic pathways drawn on the basis of sequence 
homologies should be taken with caution. Based on sequence, Drosophila might be 
expected to require mitochondrial MOMP and cyt c release for caspase activation; yet, 
unlike Apaf-1 in mammals, Dark does not appear to require cyt c to activate Dronc, and 
several reports have found no indication that cyt c is released from Drosophila 
mitochondria during apoptosis201-203. However, this is still a debated issue in the fly 
community since two recent reports showed that cyt c translocates to the cytosol in 
some types of cell death201, 204. To date, Drosophila cyt c has been linked to caspase 
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activation only during spermatid differentiation205 and to the proper timing of cell death 
in the pupal eye206. Despite the debated role of cyt c it is well accepted that the key 
players in regulation of the Drosophila apoptotic program are Diap1, a fly homolog of 
the mammalian X-linked inhibitor of apoptosis proteins (XIAP) and its antagonists 
Reaper, Hid, Grim and Sickle (RHG proteins). Diap1 is the key anti-apoptotic protein 
in Drosophila and ensures cell survival by inhibiting caspase activity207. Apoptosis is 
initiated by the binding of RHG proteins to Diap1, inducing its autoubiquitination and 
proteasome-mediated degradation and resulting in the activation of effector 
caspases208. Furthermore, it was recently found that Reaper and Hid proteins cause 
mitochondrial fragmentation and release of cyt c in both cultured S2 cells and in the 
developing fly embryo201. 
 
 
Figure 11. Schematic representation of key proteins in mitochondrial-induced apoptotic pathways in vertebrates 
and their Drosophila homologues. In healthy vertebrate cells, Apaf-1 is auto-inhibited and initiator caspase-9 as well 
as effector caspases -3 and -7 are inactive due to the binding to X-linked inhibitor of apoptosis protein (XIAP). An 
apoptotic stimulus leads to the activation of BH3-only proteins which bind to anti-apoptotic Bcl-2 proteins to remove 
their inhibitory effect or directly induce Bax/Bak channel formation which in turn triggers release of cytochrome c (cyt 
c), second mitochondria-derived activator of caspases (Smac)/direct inhibitor of apoptosis binding protein with low pI 
(Diablo), endonuclease G (endoG), apoptosis inducing factor (AIF), and Omi/HtrA2. Cyt c binds to Apaf-1 in the cytosol 
and thus induces apoptosome formation and activation of downstream caspases. Smac/DIABLO and Omi/HtrA2 bind 
to XIAP to remove its inhibitory effect.          
In Drosophila, the initiator caspase Dronc and the effector caspase Drice are ubiquitinated by Diap-1 for proteosomal 
degradation in healthy cells. Upon apoptotic signals, transcription of genes encoding for the pro-apoptotic proteins 
Reaper, Hid, Grim and sickle (RHG proteins) is induced, and RHG proteins translocate to mitochondria from where 
they recruit Diap-1 for interaction. The RHG proteins induce Diap-1 autoubiquitination and proteasomal degradation. 
Binding of Dark to mitochondria triggers apoptosome formation. dOmi might interact with the Drosophila homologue 
of the vertebrate XIAP, Diap-1 to remove the inhibitory effect of Diap-1  on caspases. Whether cyt c is released by 
Drosophila mitochondria during apoptosis is debated. Ortholog proteins in vertebrates and Drosophila are labeled in 
the same shape and color; modified from
209
. 
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Figure 12. Interaction of the key players in Drosophila cell death. In the absence of apoptotic signals, the initiator 
caspase Dronc and the effector caspase DrICE bind to the Drosophila inhibitor of apoptosis protein (Diap1), which 
ubiquitinates the caspases via its RING domain. Ubiquitylation inactivates the caspases without proteasomal 
degradation. The RING domain of Diap1 is also capable of ubiquitylating Reaper. In the presence of apoptotic stimuli, 
the RHG proteins displace the caspases from Diap1 and stimulate auto-ubiquitylation and proteasomal degradation of 
Diap1. Dronc is free to bind to the caspase activator Dark for apoptosome formation leading to activation of DrICE for 
cell death induction; modified from
208
. 
 
However, the possible lack of MOMP and cyt c release in Drosophila cell death does not 
necessarily mean that mitochondria are not important during apoptosis in flies. Indeed, 
there is strong evidence for mitochondria as a docking site to bring the key players in 
apoptosis into close proximity. Reaper, Hid and Grim were all found to localize to 
mitochondria. Hid possesses a hydrophobic C-terminal mitochondrial targeting 
sequence210 and seems to recruit the other pro-apoptotic RHG proteins via their GH3 
domain, an amphipathic helix conserved between Grim, Reaper and Sickle and essential 
for their Diap1 degradation and killing activity211. It was hypothesized that Reaper may 
be part of a high-order complex at the OMM to locally regulate Diap1 turnover and 
caspase activity 212. The Bcl-2 homologues Debcl and Buffy do not seem to play a pivotal 
role in developmental cell death in flies as analyzed in either single or double knockout 
Dark
Dark
RHG 
proteins
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flies213. Surprisingly, the fly Bcl-2 homologues are able to induce cell death in 
mammalian cells214. Taken together, these results suggest that Bcl-2 proteins in 
Drosophila can potentially induce apoptosis, and that flies can bypass the need of Bcl-2 
proteins by another regulatory strategy, i.e. transcriptional control of the potent Diap1 
inhibitors Reaper, Hid, Grim and Sickle.  Thus, Drosophila does not require the control of 
Bcl-2 proteins to regulate MOMP and the release of IAP antagonist (such as Smac and 
Omi), as is the case in mammals209. 
It is not known whether additional cell death pathways that depend on mitochondrial 
Ca2+ and oxidative stress are active in Drosophila. These pathways in mammals are 
mediated by the PTP, but whether Ca2+ transport- and PTP-dependent IMM 
permeabilization can also play a role in Drosophila was not known. This is the topic of 
my PhD work. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
49 MATERIALS AND METHODS 
 
 
 
 
 
 
 
 
 
 
 
 
MATERIALS AND METHODS 
 
 
 
 
 
 
 
 
 
 
 
 
 
50 
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I. S2R
+-cells 
I.1  Cell culture 
Cells were cultured in Schneider’s insect medium (Gibco) supplemented with 10% heat-
inactivated fetal bovine serum (culture medium). Culture medium for the transfected 
S2R
+pActCypD/pCoPuro cells was supplemented with 8 µg/µl puromycin. Depending on 
the desired culture size cells were kept in 75cm2 T flasks or in tissue culture dishes 
(245x245x25mm). S2R
+ cells grow as adherent monolayers as well as in suspension. 
Cells were incubated in a 25°C thermostated room and split every three or four days at 
1:5 to 1:10 dilutions.  
 
I.2   Cell permeabilization 
Cells were detached with a sterile cell scraper, centrifuged at 200 x g for 10 min and 
washed twice with Dulbecco’s phosphate buffered saline (PBS)  without Ca2+ and Mg2+, 
pH 7.4 (Euroclone). The resulting pellet was resuspended in 130 mM KCl, 10 mM MOPS-
Tris, pH 7.4 (KCl medium) containing 150 µM digitonin and 1 mM EGTA-Tris and 
incubated for 20 min on ice (6 x 107 cells x ml-1). Cells were then diluted 1:5 in KCl 
medium containing 10 µM EGTA-Tris and centrifuged at 200 x g in a refrigerated 
centrifuge (4°C) for 6 min. The final pellet was resuspended in KCl medium containing 
10 µM EGTA-Tris at 4 x 108 cells x ml-1 and kept on ice.  
 
I.3   Subcellular fractionation 
Cell membranes were lysed by hypotonic shock in a medium containing 10 mM Tris-
HCl, pH 6.7, 10 mM KCl, 150 µM MgCl2 supplemented with protease and phosphatase 
inhibitor cocktails (Sigma) for 30 min on ice, followed by further disruption of the cell 
membranes using a 26 G x ½" syringe (Artsana). Hypotonic shock was stopped by the 
addition of sucrose at a final concentration of 250 mM and differential centrifugation 
was performed for subcellular fractionation. Lysates were centrifuged three times at 
2,200 x g for 10 min at 4°C to remove nuclei and cell debris. The supernatant was 
centrifuged another three times at 8,200 x g for 10 min at 4°C to separate mitochondria 
from the cytoplasm.  
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I.4  Stable Transfection 
Two million cells were plated in each well of a 6-well tissue culture plate in 2 ml culture 
medium per well. Cells were incubated for 5 h at room temperature (RT) for attachment 
and then transfected with the Effectene® Transfection Reagent kit (Qiagen). Selection 
vector (pCoPuro) and expression vector (pActCypD) were used in a 1:20 ratio.  PCoPuro 
(0.3 µg) and pActCypD (6 µg) were mixed with 50.4 µl Enhancer and 543.4 µl EC-Buffer 
and incubated for 5 min at RT, followed by the addition of 60 µl Effectene. The mixture 
was incubated for 15 min at RT and then added drop-wise to the cells. After 3d the 
medium was removed and culture medium containing 8 µg/ml puromycin (selection 
medium) was added. Cells were maintained in selection medium and split to culture 
flasks when they reached confluence. The whole selection process took about three 
weeks. 
 
II. Mitochondrial bioenergetics 
II.1  Measurement of mitochondrial respiration 
Rates of mitochondrial respiration were measured using a Clark-type oxygen electrode 
(Yellow Springs Instruments, OH, USA) equipped with magnetic stirring and 
thermostatic control maintained at 25°C, and additions were made through a syringe 
port in the frosted glass stopper sealing the chamber.  Initial O2 concentration in the 2 
ml chamber at 25°C is 520 natoms O2/ml at air saturation.  Intact S2R
+ cells were 
incubated in Hank’s Balanced Salt Solution (HBSS) supplemented with 5 mM Pi-Tris, pH 
7.4 while digitonin-permeabilized cells were incubated in 130 mM KCl, 10 mM MOPS-
Tris, 5 mM Pi-Tris, 10 µM EGTA, pH 7.4. In both cases 2 x 107 cells were incubated in 2 ml 
of medium, followed by the addition of a respiratory substrate (10 mM glucose in the 
case of intact cells and 5 mM succinate-Tris in the case of permeabilized cells). Further 
additions were made as indicated in the figure legends. Addition of ADP allows 
oxidative phosphorylation to proceed, dissipating some of the protonmotive force and 
thereby stimulating electron transport (state 3 respiration). The rate of O2 consumption 
after the addition of the FOF1 ATP synthase inhibitor oligomycin (state 4 respiration) is 
an indicator of how coupled mitochondrial respiration is to ATP synthesis and the ratio 
between state 3/state 4 is called respiratory control ratio. Addition of an uncoupler 
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(protonophore) fully dissipates the protonmotive force and stimulates O2 consumption 
maximally (uncoupled respiration). When the O2 concentration falls to zero, respiration 
ceases. O2 consumption was calculated according to the slope of the registered graph, 
and plotted as ng atoms O2 x min
-1 x mg-1, or cells-1.  
 
 
Figure 13. Schematic representation of a polarographic Clark type oxygen electrode trace. Shown are effects of 
respiratory substrates, ADP, oligomycin and uncouplers on the oxygen consumption rate in coupled mitochondria. 
State 3 = ADP-stimulated coupled respiration, state 4 = basal respiration in the absence of ADP or in the presence of 
oligomycin, that is a specific inhibitor of the FOF1 ATP synthase, uncoupled respiration = stimulated respiration due to 
a proton leak of the inner mitochondrial membrane induced e.g. by an uncoupler (protonophore). 
 
II.2  Measurement of mitochondrial membrane potential  
Mitochondrial membrane potential (ΔΨm) was measured using a Perkin-Elmer 
spectrofluorometer and evaluated based on the uptake of the positively charged 
fluorescent probe Rhodamine123, which accumulates in energized mitochondria 
because of their inside negative ΔΨm. The intensity of the registered fluorescence 
corresponds to the concentration of the probe in the medium, because under the 
chosen experimental conditions intramitochondrial fluorescence of Rhodamine123 is 
quenched. Thus, the higher ΔΨm, the lower the fluorescence of Rhodamine123. Two 
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milliliters of assay medium (130 mM KCl, 10 mM MOPS-Tris, 5 mM Pi-Tris, 10 µM EGTA, 
0.15 µM Rhodamine123, pH 7.4) were added to the cuvette. The fluorescence of 
Rhodamine123 was monitored at the excitation and emission wavelengths of 503 and 
523 nm, respectively, with the slit width set at 2.5 nm. After a short incubation to reach 
stabilization of the signal, 2 x 107 permeabilized S2R
+ cells were added to the cuvette. 
Further additions were as indicated in the figure legends. 
 
 
Figure 14. Evaluation of mitochondrial membrane potential (ΔΨm) based on Rhodamine123 fluorescence. Shown is a 
scheme illustrating a typical trace recorded at a fluorimeter. 
 
III. Mitochondrial Ca2+ transport and permeability transition 
III.1 Measurement of mitochondrial Ca2+ fluxes and Ca2+ retention capacity  
The mitochondrial CRC-assay was used to assess opening of the Drosophila Ca2+-
induced Ca2+ release channel in permeabilized S2R
+ cells. The Ca2+ threshold needed to 
open the channel can be determined by adding Ca2+-pulses of known concentrations at 
short intervals. Opening of the Ca2+-induced Ca2+ release channel is marked by a sudden 
release of the accumulated Ca2+. Extramitochondrial Ca2+ was measured with Calcium 
Green 5N (Molecular Probes) using either a Perkin-Elmer LS50B spectrofluorometer 
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equipped with magnetic stirring (excitation and emission wavelengths of 505 and 535 
nm, respectively) or a Fluoroskan Ascent FL (Thermo Electron Corp.) equipped with a 
plate shaker (excitation and emission wavelengths of 485 and 538 nm, respectively with 
a 10-nm bandpass filter). The incubation medium contained 130 mM KCl or 250 mM 
sucrose, 10 mM MOPS-Tris, 5 mM succinate-Tris, 10 µM EGTA, 2 µM rotenone, 0.5 µM 
Calcium Green 5N, pH 7.4 and Pi-Tris as indicated in the figure legends. Permeabilized 
cells (2 x 107 in a final volume of 2 ml in the Perkin-Elmer spectrofluorometer and 2 x 106 
in a final volume of 0.2 ml in the Fluoroskan) were used. Further additions were made as 
indicated in the figure legends. 
Calcium Green 5N is a Ca2+-sensitive dye, not permeable to the mitochondrial inner 
membrane. Therefore, adding a Ca2+-pulse to the cell suspension leads to a peak in 
Calcium Green 5N fluorescence, followed by an immediate decrease of the latter when 
Ca2+ is taken up by mitochondria. When a threshold-concentration of matrix Ca2+ is 
reached, the Ca2+-induced Ca2+ release channel opens, which leads to a release of Ca2+ 
out of the mitochondria and thus to a quick increase in Calcium Green 5N fluorescence. 
 
Figure 15. Calcium Retention Capacity (CRC) assay. Extramitochondrial Ca
2+
 is measured fluorimetrically by the Ca
2+
-
sensitive dye Calcium Green 5N. Addition of a Ca
2+
 pulse to the mitochondria or permeabilized cells leads to increase 
in fluorescence (1) followed by an immediate decrease of the latter when Ca
2+
 is taken up by mitochondria (2). When 
a threshold concentration of Ca
2+ 
accumulated in the matrix is reached, the Ca
2+
-induced Ca
2+
 release channel opens 
leading to a quick increase in fluorescence (3). 
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III.2 Light scattering 
The light scattering technique is based on the correlation between mitochondrial 
matrix volume and the optical density of the mitochondrial suspension. Intact 
mitochondria scatter light at 540-nm wavelength. An increase in matrix volume due to 
mitochondrial swelling leads to a decrease in light scattering. Light scattering at 90° 
was monitored with a Perkin-Elmer LS50B spectrofluorimeter at 540 nm with a 5.5 nm 
slit width. Twenty million permeabilized cells in a final volume of 2 ml were incubated in 
a medium containing 130 mM KCl, 10 mM MOPS-Tris, 5 mM succinate-Tris, 10 µM 
EGTA, 2 µM rotenone, pH 7.4 and Pi-Tris as indicated in the figure legends.  
 
Figure 16. Schematic representation of the light scattering technique as indicator of mitochondrial volume changes. 
Addition of alamethicin (a pore-forming peptide) or valinomycin (a K
+
-ionophore) to a mitochondrial or permeabilized 
cell suspension leads to a decrease in light scattering indicating mitochondrial swelling (b), (a) = control trace without 
any additions. 
 
IV. Epifluorescence microscopy 
IV.1 Fluorescent staining of S2R
+ cell mitochondria 
Energization of mitochondria in both intact and permeabilized S2R
+ cells was analyzed 
based on accumulation of the potentiometric probe tetramethyl rhodamine methyl 
ester (TMRM, Molecular Probes), that accumulates in mitochondria based on their 
inside-negative ΔΨm. Three days before the experiments cells were seeded onto 
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sterilized 24-mm round glass coverslips at 2 x 106 cells per well in 2 ml culture medium. 
On the day of experiment cells were washed once with PBS and incubated for 20 min at 
RT with 1 ml of serum-free Schneider’s medium supplemented with 1 µg/ml Cyclosporin 
H (CsH) and 10 nM TMRM. CsH is an inhibitor of the plasma membrane multidrug 
resistance pumps that does not affect the PTP of mammals and allows an appropriate 
loading with the probe by preventing its extrusion at the plasma membrane215, 216. 
Images were acquired with an Olympus IX71/IX51 inverted microscope equipped with a 
xenon light source (75 W) for epifluorescence illumination, and with a 12-bit digital 
cooled CCD camera (Micromax). For detection of TMRM fluorescence, 568 ± 25-nm 
bandpass excitation and 585-nm longpass emission filter settings were used. 
 
IV.2 Immunofluorescence 
One day before the experiments stably transfected S2R
+pActCypD cells were seeded on 
sterilized 13-mm round glass coverslips in a 24-well tissue culture plate at 2 x 105 cells 
per well in 0.5 ml of culture medium. On the day of experiment cells were washed once 
with PBS and incubated for 20 min at RT with 0.5 ml of serum-free Schneider’s medium 
supplemented with 1 µg/ml CsH and 100 nM Mitotracker® Red CMXRos (Molecular 
Probes) for mitochondrial staining. After another washing step with PBS, cells were 
fixed with 4% paraformaldehyde for 20 min at RT. Cells were washed again with PBS, 
permeabilized with 50 mM NH4Cl in PBS + 0.1% Triton for 5 min at RT, washed again 
and blocked with PBS containing 3% goat serum for 1h at RT. Monoclonal anti-HA 
(clone HA-7, Sigma) diluted 1:100 in PBS with 2% goat serum was added to the cells and 
incubated over night at 4°C. On the next day cells were washed 3 times with PBS and 
the immunoreaction was revealed with FITC-conjugated anti-mouse IgG (Fab-specific, 
Sigma) at a working dilution of 1:500 in PBS with 2% goat serum for 45 min at RT. After 
another three washings in PBS coverslips were mounted with Mowiol and examined 
with an Olympus epifluorescence microscope at 60x magnification.  
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V. Electron  microscopy 
S2R
+ cells were washed with PBS and fixed in 2.5% glutaraldehyde in 0.1 M K+ 
phosphate buffer pH 7.4 for 2 h at 4°C. After washing with 0.15 M K+ phosphate buffer 
pH 7.0 cells were finally embedded in 2% gelatin as previously described217. Gelatin-
embedded samples were post-fixed with 1% osmium tetroxide in cacodylate buffer 0.1 
M, pH 7.4, and embedded in Epon812 resin, sectioned and stained following standard 
procedures218.  Ultrathin sections were observed with a Philips EM400 transmission 
electron microscope operating at 100 Kv. 
 
VI. SDS-PAGE and Western Blotting 
VI.1 Sample preparation  
Cells were pelleted at 3,000 x g and mitochondria at 8,200 x g at 4°C and resuspended in 
a lysis buffer (LB) containing 150 mM NaCl, 20 mM Tris, pH 7.4, 5 mM EDTA-Tris, 10% 
Glycerol, 1% Triton X-100, supplemented with protease and phosphatase inhibitor 
cocktails (Sigma), and kept on ice for 20 min. Lysates were then centrifuged at 18,000 x 
g for 25 min at 4°C to remove insoluble materials. The supernatants were solubilized in 
Laemmli gel sample buffer containing 10% sodium dodecyl sulfate (SDS), 250 mM Tris, 
pH 6.8, 50% glycerol, 12.5% ß-mercaptoethanol and 0.02% bromophenol blue. 
Cytoplasmic fractions and post-cellular supernatants were concentrated by adding five 
volumes -20°C acetone to one volume of sample. Samples were kept overnight at -20° 
and finally centrifuged at 18,000 x g for 30 min at 4°C. The pellets were resuspended in 
20% methanol, centrifuged again at 18,000 x g for 15 min at 4°C and finally solubilized 
in Laemmli gel sample buffer. 
 
VI.2 SDS-PAGE  
All samples to be run on the SDS-PAGE were previously solubilized in Laemmli gel 
sample buffer and denatured by boiling for 5 min. Samples were then loaded and 
separated electrophoretically in a 15% polyacrylamide gel.  
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VI.3 Western Blotting 
Separated proteins were transferred electrophoretically to nitrocellulose membranes in 
a buffer containing 0.5 M glycine, 0.4 M Tris and 20% methanol at 4°C using a Mini 
Trans-Blot system (Bio-Rad). The membrane was then saturated for 1 h in PBS 
containing 3% nonfat dry milk and 0.02% Tween to avoid non-specific protein binding. 
Saturated membranes were incubated with a primary antibody overnight at 4°C. The 
next day membranes were washed three times in PBS/ 0.02% Tween for 5 min each and 
incubated with a secondary horseradish peroxidase-conjugated antibody (anti-mouse, 
anti-rabbit or anti-goat, depending on the source of the primary antibody) in PBS 
containing 3% nonfat dry milk and 0.02% Tween for 1 h and 30 min at RT. After another 
three washings, the antibody protein binding was revealed by the ECL (Enhanced 
ChemiLuminescence; Milipore) kit.  
 
antibody source company dilution 
anti-cytochrome c mouse 
monoclonal 
BD Pharmingen 1:500 
anti-OxPhos complex IV 
subunit I 
mouse 
monoclonal 
Invitrogen 1:500 
anti-TOM20 rabbit 
polyclonal 
Santa Cruz 
Biotechnology 
1:300- 
1:500 
anti-HA mouse 
monoclonal 
Sigma 1:1000 
anti-Cyp-D mouse 
monoclonal 
Calbiochem 1:1000-
1:3000 
anti-actin goat 
polyclonal 
Santa Cruz 
Biotechnology 
1:1000 
anti-caspase3 rabbit 
polyclonal 
Cell Signalling  1:1000 
 
Table 1.  List of all primary antibodies for Western Blotting used in this work.  
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VII. Plasmids and constructs 
VII.1 Cloning of human Cyp-D cDNA into a Drosophila expression vector 
Total RNA was extracted from the human osteosarcoma cell line HQB17 with TRIzol® 
Reagent (Invitrogen) according to the manufacturer’s protocol. cDNA was synthesized 
using SuperScriptTM II Reverse Transcriptase  (Invitrogen), following the manufacturer’s 
instructions. A construct of human Cyp-D cDNA carrying a mitochondrial targeting 
sequence (MTS) from Drosophila Hsp60 (a mitochondrial matrix protein) at its 5’ end 
and an HA-tag at its 3’ end was created by polymerase chain reaction (PCR) using a 
forward primer carrying the MTS and a reverse primer carrying the HA-tag. Exchange of 
the human MTS for a Drosophila MTS was meant to assure proper localization of the 
heterologous protein in the mitochondrial matrix upon translation in the Drosophila cell 
line, and the attachment of the nonapeptide HA (YPYDVPDYA) at the C-terminus was 
aimed to facilitate the detection of the heterologous protein by Western Blot or 
Immunofluorescence analysis. Long primers K_MTSCYPD_FWD and S_HACYPD_REV 
were used for generation of the MTS_CypD_HA construct from human cDNA by PCR. 
The second shorter primer pair (K_MTS_FWD and S_HA_REV) was used for screening 
of proper insertion in the vector by colony PCR, as described below. 
name sequence 
K_MTSCYPD_FWD ctGGTACCATGTTCCGTTTGCCAGTTTCGCTTGCTCGCTCCTCCA
TTAGCCGCCAGTTGGCCATGCGCGGCTATGCCAAGGATGTGTG
CAGCAAGGGCTCCGGCGACCCG 
S_HACYPD_REV ccGAGCTCTTAAGCGTAATCTGGAACATCGTATGGGTAGCTCAA
CTGGCCACAGTCTGTGATG 
K_MTS_FWD ctGGTACCATGTTCCGTTTGCCAGTTTCGCTTG 
S_HA_REV ccGAGCTCTTAAGCGTAATCTGGAACATCGTATG 
Table 2. Primers used for generation of a cDNA MTS-CypD-HA construct. Forward (FWD) and reverse (REV) primer 
contain cleavage sites for the restriction enzymes KpnI GGTACC and SacI GAGCTC (in red). 
 
PCRs were performed in a 50 μl reaction mixture containing: 
- 100 ng cDNA 
- 25 µl 2x Phusion® High-Fidelity Master Mix with HF Buffer (Finnzymes) 
- 10 µM primer K_MTSCYPD_FWD 
- 10 µM primer S_HACYPD_REV 
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cycle step temperature time cycles 
denaturation 98°C 5 min 1 
denaturation 
annealing 
extension 
98°C 
60°C 
72°C 
30 sec 
30 sec 
1 min 
 
30 
final extension 72°C 10 min 1 
Table 3. PCR amplification protocol for generation of a cDNA MTS-CypD-HA construct. 
 
A further incubation step at 72°C for 10 min was performed with GoTaq® DNA 
polymerase (Promega) to add an adenine (A)-overhang at the 3’ end of the PCR 
product. 
 
 
Figure 17. cDNA sequence of the MTS-CypD-HA construct. The mitochondrial targeting sequence (MTS) of the human 
Cyp-D sequence was exchanged for an MTS of Drosophila Hsp60 (a mitochondrial matrix protein; cyan) in order to 
assure proper mitochondrial localization of the heterologous protein in Drosophila. The sequence encoding for an HA-
tag (pink) was attached to the 3’ end of the human Cyp-D cDNA sequence (yellow) in order to facilitate detection of 
the protein. Restriction enzyme sites attached to the 3’ and 5’ ends are not shown. 
 
The obtained 654 bp PCR product was ligated into the pGEM®-T vector (Promega) 
according to the manufacturer’s instructions and the resulting vector was used to 
transform One Shot TOP10 E. coli cells (Invitrogen).  
MTS Hsp60 Drosophila
HA Tag
human Cyp-D cDNA
ATGTTCCGTTTGCCAGTTTCGCTTGCTCGCTCCTCCATTAGCCGCCAGTTGGCCATGC
GCGGCTATGCCAAGGATGTGTGCAGCAAGGGCTCCGGCGACCCGTCCTCTTCCTCCTCCTCCGGGA
ACCCGCTCGTGTACCTGGACGTGGACGCCAACGGGAAGCCGCTCGGCCGCGTGGTGCTGGAGCTGA
AGGCAGATGTCGTCCCAAAGACAGCTGAGAACTTCAGAGCCCTGTGCACTGGTGAGAAGGGCTTCG
GCTACAAAGGCTCCACCTTCCACAGGGTGATCCCTTCCTTCATGTGCCAGGCGGGCGACTTCACCA
ACCACAATGGCACAGGCGGGAAGTCCATCTACGGAAGCCGCTTTCCTGACGAGAACTTTACACTGA
AGCACGTGGGGCCAGGTGTCCTGTCCATGGCTAATGCTGGTCCTAACACCAACGGCTCCCAGTTCT
TCATCTGCACCATAAAGACAGACTGGTTGGATGGCAAGCATGTTGTGTTCGGTCACGTCAAAGAGG
GCATGGACGTCGTGAAGAAAATAGAATCTTTCGGCTCTAAGAGTGGGAGGACATCCAAGAAGATTG
TCATCACAGACTGTGGCCAGTTGAGCTACCCATACGATGTTCCAGATTACGCTTAA
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Figure 18. pGEM®-T vector map and sequence reference points.  
 
Positive clones were detected by β-galactosidase screening and colony PCR. 
Furthermore, all the constructs were fully sequenced to assess the in-frame insertion of 
the cDNA and to control for unwanted mutations (BMR Genomics).  
 
The 50 µl reaction mixture for colony PCR contained: 
- 3 µl bacterial suspension grown overnight from a single colony 
- 5 µl 10x PCR buffer  
- 10 µM primer K_MTS_FWD 
- 10 µM primer S_HA_REV 
- 25 mM MgCl2 
- 10 mM dNTPs (10 mM each dATP, dTTP, dGTP, dCTP) 
- 2.5 u GoTaq® DNA polymerase (Promega) 
 
cycle step temperature time cycles 
denaturation 95°C 10 min 1 
denaturation 
annealing 
extension 
95°C 
58°C 
72°C 
45 sec 
45 sec 
1 min 
 
30 
final extension 72°C 10 min 1 
Table 4. Colony PCR amplification protocol for detection of MTS-CypD-HA-positive clones. 
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Using conventional restriction enzyme digestion techniques, the MTS_CypD_HA 
sequence was extracted with SacI from the pGEM®-T vector (SacI cuts at the 3’ end of 
the MTS_CypD_HA insert as well as upstream the 5’ end in the multiple cloning site of 
the pGEM®-T vector) and ligated into the pAct Drosophila transformation vector, which 
was linearized with the same restriction enzyme. The resulting pActCypD vector 
contains the MTS_CypD_HA construct under the control of the Drosophila actin 5C 
promoter, which drives constitutive expression of the heterologous protein. Positive 
clones were detected with colony PCR, as described above.  The vector was purified by 
Miniprep and sequenced again in order to screen for plasmids containing the 
MTS_CypD_HA construct inserted in the right direction.  
 
 
Figure 19. pAct vector map. 
 
The expression vector pActCypD was co-transfected with the selection vector pCoPuro 
(Addgene plasmid 17533, coding for puromycin-resistance) into Drosophila S2R
+ cells, in 
order to generate a stable polyclonal cell population, constitutively expressing human 
Cyp-D. Transfection procedure and selection process were performed as described 
above. 
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Figure 20. pCoPuro vector map and sequence reference points. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Feature Name Start End 
pGEX_3_primer 51 29
lacZ_a 393 250
M13_pUC_fwd_primer 364 386
M13_forward20_primer 379 395
puro (variant) 894 1493
pBluescriptKS_primer 1643 1627
SV40_PA_terminator 1661 1792
EBV_rev_primer 1749 1768
M13_pUC_rev_primer 1855 1833
lac_promoter 1898 1869
pBR322_origin 2826 2207
Ampicillin 3841 2981
AmpR_promoter 3911 3883
pCoPuro
4041 bp
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67 RESULTS 
Part I: Properties of a Selective Ca2+-induced Ca2+ Release 
Channel in Mitochondria of Drosophila melanogaster  
 
Mitochondria are key players in cellular Ca2+ homeostasis and are thereby involved in a 
wide field of physiological processes such as buffering of cytoplasmic Ca2+ signals, 
excitation-contraction coupling and induction of cell death. Indeed, the mitochondrial 
proton electrochemical gradient ΔμH is used not only to synthesize ATP but also to 
accumulate cations into the mitochondrial matrix. Ca2+ uptake into respiring 
mitochondria is mediated by the mitochondrial Ca2+ uniporter (MCU), localized in the 
inner mitochondrial membrane (IMM), while exchangers (Ca2+ for Na+ and ⁄ or H+) are 
responsible for Ca2+ efflux. However, mitochondria are exposed to the danger of Ca2+ 
overload when matrix Ca2+ load exceeds the capacity of IMM exchangers and thus, an 
additional Ca2+ efflux pathway may exist in mitochondria through opening of the 
permeability transition pore (PTP). The mitochondrial permeability transition (PT) 
describes a process of Ca2+-dependent, tightly regulated increase in the permeability of 
the IMM due to the opening of a high-conductance channel, the PTP. Prolonged 
opening of the PTP causes mitochondrial depolarization, loss of ionic homeostasis, 
depletion of pyridine nucleotides, respiratory inhibition, matrix swelling, release of 
cytochrome c and cell death via apoptosis or necrosis depending on a variety of 
additional factors, among which cellular ATP and Ca2+ levels play a major role. On the 
other hand, transient openings of the PTP (flickering) may be involved in physiological 
Ca2+ homeostasis. The PTP has been thoroughly characterized based on its sensitivity 
to a large number of effectors, but its molecular nature remains elusive. 
In spite of its importance as a model organism, remarkably little was known about the 
properties of Ca2+ transport in mitochondria of the fruit fly Drosophila melanogaster, 
and on whether these mitochondria can undergo a PT. Thus, we studied the pathways 
for Ca2+ transport in mitochondria in the embryonic Drosophila cell line S2R
+ and 
identified a selective mitochondrial Ca2+-dependent Ca2+ release channel displaying 
features intermediate between the mammalian PTP and the pore of yeast. The results 
of this study are illustrated in Publication 1 and the conclusions are summarized in the 
final Section of this Thesis.  
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Publication 1 
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Supplemental Material for 
 
Properties of Ca2+ Transport in Mitochondria of 
Drosophila melanogaster 
 
Sophia von Stockum, Emy Basso, Valeria Petronilli, Patrizia Sabatelli, Michael A. Forte, 
Paolo Bernardi 
 
 
 
Supplementary Figure 1. Oxygen consumption rates in intact and permeabilized Drosophila S2R
+
 cells. A, 
cells were incubated in Hank’s balanced salt solution supplemented with 10 mM glucose and 5 mM Pi-Tris, 
pH 7.4 and respiration recorded with a Clark-type oxygen electrode under basal conditions, after the 
addition of 1 μg/ml oligomycin followed by that of 50 nM FCCP. B, digitonin-permeabilized cells were 
incubated in 130 mM KCl, 10 mM MOPS-Tris, 5 mM succinate-Tris, 5 mM Pi-Tris and 10 μM EGTA-Tris, pH 
7.4 and basal respiration measured, followed by the addition of 0.1 mM ADP, 1 μg/ml oligomycin and 50 
nM FCCP. Respiratory rates are average ± SD from three independent experiments. 
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Supplementary Figure 2. Effect of CsA, Ub0, ADP and oligomycin on CRC of permeabilized Drosophila 
S2R
+
 cells. Experimental conditions were as in Fig. 2 except that the concentration of Pi was 5 mM (A) or 1 
mM (B). The CRC was determined in protocols identical to those shown in Fig. 4 in the absence of further 
additions (ctrl), or in the presence of 2 μg/ml CsA, 5 μM Ub0 or 0.1 mM ADP plus 1μg/ml oligomycin 
(Oligo). CRC values are normalized to those observed in absence of additions other than Ca2+ (CRC0). 
Experiments were performed in triplicate and reported values are average ± SD. 
 
 
Supplementary Figure 3. Effect of valinomycin and alamethicin on light scattering in permeabilized 
Drosophila S2R
+
 cells. Experimental conditions were as in Fig. 2, and 90° light scattering changes were 
measured at 540 nm. Where indicated 150 nM (trace b) or 1 μM (trace c) valinomycin (Val) and 3 μM 
alamethicin (Ala) were added. Trace a, no valinomycin. The figure shows representative traces from three 
independent experiments. 
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Part II: Expression of Human Cyclophilin D in Drosophila 
melanogaster Cells – Impact on Regulation of the Drosophila 
Mitochondrial Ca2+ Release Channel 
 
A key modulator of the mammalian permeability transition pore (PTP) is Cyclophilin D 
(Cyp-D), a mitochondrial peptidyl-prolyl-cis-trans isomerase (PPIase) that in mice is 
encoded by the Ppif gene and that plays an important role in protein folding. Cyp-D can 
be selectively inhibited by the immunosuppressant drug Cyclosporin A (CsA) and 
genetic Cyp-D ablation (or treatment with CsA)  remarkably desensitizes the PTP in 
that its opening requires about twice the Ca2+ load necessary to open the PTP in ctrl 
mitochondria. Recently, it was shown that the desensitizing effect of Cyp-D ablation or 
CsA treatment on the pore is only seen in the presence of Pi, but not when the latter is 
replaced by its analogues arsenate or vanadate. These results suggest that when Cyp-D 
does not bind to the PTP (because of genetic ablation or of the binding to CsA) Pi can 
bind to an inhibitory site on the pore thereby delaying pore opening68.  
The Drosophila genome encodes for fourteen different Cyclophilins. However, 
according to sequence analysis219 and GFP-tagging (unpublished results) there is no 
Drosophila Cyclophilin with a predicted mitochondrial localization. As described in Part 
I, the Drosophila Ca2+-induced Ca2+ release channel has some similar characteristics to 
the mammalian PTP, but possesses also some unique features in that it is insensitive to 
CsA, selective to Ca2+ and H+ and inhibited by Pi. Another striking difference between 
the pore of Drosophila and that of mammals is the lack of mitochondrial swelling and 
cytochrome c release during the opening of the channel. Taken together, these results 
suggest that the PTP is a phenomenon conserved throughout evolution, although it is 
regulated in different manners in different species. In this second part of the study, we 
investigated if the lack of sensitivity of the Drosophila channel to CsA is due to a lacking 
mitochondrial Cyclophilin and what the evolutionary role of Cyp-D is in pore regulation. 
Thus, we stably expressed a human Cyp-D construct in the Drosophila embryonic cell 
line S2R
+ in order to investigate the impact of the heterologous protein on regulation of 
the Drosophila Ca2+-induced Ca2+ release channel.  
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In order to express the human Cyp-D protein in S2R
+ cells, we cloned a construct of 
human Cyp-D cDNA carrying a Drosophila MTS at its 5’ end and an HA-tag at its 3’ end 
in the Drosophila expression vector pAct, that drives constitutive expression of the 
heterologous protein. 
Exchange of the human MTS for a Drosophila MTS was meant to assure proper 
localization of Cyp-D in the mitochondrial matrix upon translation in the Drosophila cell 
line, and the attachment of an HA-tag at the C-terminus was aimed at facilitating the 
detection of the heterologous protein by Western Blot or Immunofluorescence analysis. 
Cells were transfected with the expression vector pActCypD and the selection vector 
pCoPuro (encoding for puromycin-resistance) in a 20:1 ratio in order to minimize the 
occurrence of cells containing the selection but not the expression vector. A careful 
titration of puromycin was performed in order to define the proper concentration able 
to kill non-transfected ctrl cells but not puromycin-resistant pActCypD/pCoPuro cells.  
Puromycin-resistant cells were selected over three weeks to obtain a stable polyclonal 
cell population.  
First, we wanted to analyze if and to what extend the transfected cells express human 
Cyp-D. Therefore we performed Western Blot analysis of total cell lysates and 
subcellular fractions, showing that S2R
+ pActCypD-HA cells express the heterologous 
Cyp-D in a comparable amount to a human osteosarcoma cell line (SAOS) expressing 
the endogenous form (Figure 21 A) and that heterologous Cyp-D is mostly localized in 
the mitochondria (Figure 21 B). The faint band of Cyp-D in the cytoplasmic fraction 
could be due to the very high expression of the heterologous protein under the control 
of the actin 5C promoter. Mitochondrial localization of human Cyp-D in S2R
+ cells was 
confirmed by Immunofluorescence analysis (Figure 21 C). 
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Figure 21. Expression level and subcellular localization of human Cyclophilin D expressed in Drosophila S2R
+
 cells. (A) 
Western Blot analysis of total cell lysates from non-transfected S2R
+
 cells (S2R
+
 ctrl), S2R
+
 cells stably transfected with 
pAct-CypD and pCoPuro vectors (S2R
+
pActCyp-D-HA) and human osteosarcoma cells (SAOS). Immunoblotting was 
performed with antibodies against Cyp-D, HA-tag and actin as internal loading control. The slight difference in 
molecular weight between the heterologously and the endogenously expressed Cyp-D is due to the HA-tag. (B) 
Western Blot analysis of cytosolic and mitochondrial fractions from S2R
+
pActCyp-D-HA showing the subcellular 
localization of Cyp-D. Antibodies against caspase-3 (Casp-3) and translocase of outer membrane 20 (TOM20) were 
used as markers for cytosol and mitochondria, respectively and were meant to address the purity of subcellular 
fractions. (C) Subcellular localization of Cyp-D in S2R
+
pActCyp-D-HA addressed by Immunofluorescence. Mitochondria 
were stained with Mitotracker Red CMXRos (red fluorescence) and cells were incubated with a specific antibody 
against the HA-tag attached to Cyp-D, followed by incubation with FITC-conjugated anti-mouse IgG (green 
fluorescence). The right panel shows the merged image from red and green fluorescence.  
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In order to address the impact of human Cyp-D on the Drosophila Ca2+-induced Ca2+ release 
channel we studied the CRC in cells co-transfected with the expression vector pActCypD and the 
selection vector pCoPuro compared to ctrl cells transfected exclusively with the pCoPuro vector. 
Cyp-D expression strikingly reduced the CRC in pActCypD/pCoPuro cells compared to ctrl cells 
irrespective of the Pi concentration (Figure 22 A, panels a and a’). CsA was not able to prevent 
the inducing effect of Cyp-D on the Drosophila Ca2+-induced Ca2+ release channel (Figure 22 A, 
panels b and b’) and was ineffective in ctrl cells, as shown in Part I. We believe that Cyp-D acts 
specifically on the Ca2+ release channel since the potent PTP inhibitor rotenone73 restored the 
CRC in Cyp-D-expressing cells, which became able to accumulate Ca2+ in a comparable amount to 
ctrl cells (Figure 22 A, panels c and c’). Figure 22 A shows an extreme case in which Cyp-D 
expression led to immediate opening of the Drosophila Ca2+-induced Ca2+ release channel and 
prevented any Ca2+ uptake by mitochondria.  Figure 22 B shows ratios of CRCs in the absence or 
presence of Cyp-D (in the latter case of course only experiments where some Ca2+ uptake took 
place were considered). The lack of sensitivity to CsA might be due to a very high affinity of the 
human Cyp-D for the Drosophila pore and/or to the high abundance of the overexpressed Cyp-D, 
which may require higher CsA concentrations for displacement from the Ca2+ release channel, an 
issue that will be addressed in the future. 
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Figure 22. Effect of human Cyp-D on mitochondrial Ca
2+
 retention capacity (CRC) in permeabilized Drosophila S2R
+
 
cells. (A) Digitonin-permeabilized S2R
+
 cells transfected either with pActCypD expression vector and pCoPuro selection 
vector (Cyp-D, panels a’-c’) or only with the selection vector (ctrl, panels a-c) were incubated in 250 mM sucrose, 10 
mM MOPS-Tris, 5 mM succinate-Tris, 10 µM EGTA, 0.5 µM Calcium Green 5N, pH 7.4 and Pi-Tris, as shown in the 
figure. In panels b and b’ the medium was supplemented with 0.8 µM CsA and in panels c and c’ with 2 µM rotenone. 
Extramitochondrial Ca
2+ 
was monitored, and CRC was determined by stepwise addition of 5 µM Ca
2+
 pulses. (B) The 
amount of Ca
2+
 accumulated prior to onset of Ca
2+
-induced Ca
2+
 release without further additions, in the presence of  
2 µM rotenone (+ rotenone) or 0.8 µM CsA (+ CsA) was normalized to that obtained in the ctrl cells. Note that only the 
values where some Ca
2+
 uptake could be observed were included in this graph. Error bars report the standard 
deviation of three different experiments. 
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85 CONCLUSIONS 
In this study we characterized Ca2+ transport mechanisms in one of the most popular 
and widely used model organism, Drosophila melanogaster. In particular we identified a 
novel mitochondrial Ca2+-dependent Ca2+ release channel in a digitonin-permeabilized 
embryonic Drosophila cell model, displaying features intermediate between the 
mammalian PTP and the pore of yeast. Like the mammalian PTP, Drosophila Ca2+ 
release is inhibited by tetracaine and opens in response to matrix Ca2+ loading, inner 
membrane depolarization, thiol oxidation, and treatment with relatively high 
concentrations of NEM. Like the yeast pore (and at variance from the mammalian PTP), 
the Drosophila channel is inhibited by Pi and insensitive to CsA. A striking difference 
between the pore of Drosophila and that of mammals is its selectivity to Ca2+ and H+ and 
the lack of mitochondrial swelling and cyt c release during the opening of the channel. 
Available evidence points to persistent activation of the PTP as a prime mediator of 
apoptotic and necrotic cell death in mammals. As described in Chapter 5.4, 
permeabilization of mitochondrial membranes might not be required to induce the 
Drosophila apoptotic pathways and cyt c seems to be dispensable for activation of 
down-stream caspases. However, it is unknown if Ca2+-mediated cell death pathways 
do exist in Drosophila cells. Our results indicate that the Drosophila Ca2+-induced Ca2+ 
release channel might be more involved into Ca2+ homeostasis than into cell death 
induction due to the fact that its opening does not cause morphological changes and 
membrane permeabilization in mitochondria. However, this issue can now be 
addressed based on the results of the second part of this study, in which we were able 
to express human Cyp-D in Drosophila S2R
+ cells. The heterologous protein was properly 
targeted to the mitochondria and decreased the Ca2+ retention capacity of Cyp-D-
expressing cells in a rotenone-sensitive but CsA-insensitive manner. If the Cyp-D in 
Drosophila cells changes selectivity, size and properties of the Ca2+-induced Ca2+ release 
channel can now be addressed. It will be particularly interesting to investigate if Cyp-D 
induces the swelling of mitochondria undergoing Ca2+ release, and if mitochondria do 
now release cyt c. This could shed further light on the evolution of the PTP and 
mitochondria-mediated cell death pathways in the animal kingdom.  Furthermore, we 
can benefit from the sophisticated genetic strategies that Drosophila provides to define 
the molecular nature of the PTP and its role in pathophysiology of Ca2+ homeostasis. 
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